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1. Introduction
While odontogenic infections are daily encountered in dental and oral and maxillofacial sur‐
gery practices, some practitioners may be unfamiliar with the wide range of other infections
of diverse etiology, some of them relatively uncommon, or even rare. Patients so affected
come to their attention either through referrals from primary care providers or due to pa‐
tients’ uncertainty about where to seek help for diseases manifesting themselves in the oro‐
facial area. Also in hospital environment, where majority of oral and maxillofacial surgeons
practice, one regularly receives requests for consultations about patients who need interdis‐
ciplinary cooperation despite the fact that their conditions primarily belong to the sphere of
specializations like ENT surgery, ophthalmology, dermatology and others. The purpose of
this chapter is to provide an update on such conditions and demonstrate the ways oral and
maxillofacial surgeon can participate in their diagnosis and management.
2. Facial skin infections
2.1. Impetigo
Impetigo is a highly contagious infection of the superficial epidermis. It is usually caused by
Staphylococcus aureus or Group A streptococci [1]. The form of impetigo that penetrates
deeper into the dermis and may leave a scar is called ecthyma. Impetigo occurs most fre‐
quently among economically disadvantaged children aged 2–5 years, although older chil‐
dren and adults may also be afflicted under conditions of poor hygiene, high humidity and
warm temperatures. Prospective studies of streptococcal impetigo have demonstrated that
the responsible microorganisms initially colonize the unbroken skin. Inoculation of surface
organisms into the skin happens after a mean interval of 10 days by abrasions, minor trau‐
ma, or insect bites [2].
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2.1.1. Clinical presentation
The most frequent locations of impetigo are the face and extremities. Two clinical forms are
recognized: non-bullous and bullous. The lesions of non-bullous impetigo begin as papules
that rapidly evolve into vesicles surrounded by an area of erythema. Then they become pus‐
tules that gradually enlarge and break down over a period of 4–6 days to form characteristic
golden yellow crusts [3]. (Figure 1)
Figure 1. Non-bullous impetigo of paranasal skin with a central denuded area and peripheral crust.
Bullous lesions appear initially as superficial vesicles that rapidly enlarge to form flaccid
bullae filled with clear yellow fluid, which later becomes darker, more turbid, and some‐
times purulent. The bullae may rupture, often leaving a thin brown crust resembling lacquer
[4]. The lesions heal slowly and leave depigmented areas. Bullous impetigo is caused by
strains of S. aureus that produce a toxin causing cleavage in the superficial skin layer. In the
past, nonbullous lesions were usually caused by streptococci. Now, most cases are caused
by staphylococci alone or in combination with streptococci [5].
2.1.2. Treatment
The therapeutic approach to impetigo depends on the number of lesions, their extent and
location (in a face proximity to eyelids or mouth), and the need to limit spread of infection to
other individuals. The best topical agent is mupirocin, although resistance has been descri‐
bed; other agents, such as bacitracin and neomycin, are considerably less effective. Topical
therapy with mupirocin is equivalent to oral systemic antimicrobials and may be used when
lesions are limited in number. Patients who have numerous lesions or who are not respond‐
ing to topical agents should receive oral antibiotics effective against both S. aureus and Strep‐
tococcus pyogenes. The preferred antibiotics are penicillinase resistant penicillins or first-
generation cephalosporins, because S. aureus currently accounts for most cases of bullous
impetigo, as well as for a substantial portion of nonbullous infections [3].
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2.2. Folliculitis
Folliculitis is defined as purulent infection of hair follicles limited to the epidermis. Predis‐
posing factors are hot and humid conditions, obesity, diabetes mellitus, long-term antibiotic
or corticosteroid use, and immunosuppression [1].
2.2.1. Clinical presentation and etiology
Folliculitis is characterized by clusters of small, erythematous papules or pustules, usually
in body areas prone to friction and heavy perspiration. The face belongs to the most often
involved areas. The most common form of folliculitis is sycosis barbae a staphylococcal infec‐
tion related to shaving. (Figure 2)
Figure 2. Sycosis barbae with peripheral cellulitis.
The fungal counterpart of sycosis barbae is tinea barbae caused by various dermatophytes.
Other possible etiological agents include Enterobacteriaceae (often associated with prolonged
antibiotic therapy), Pseudomonas aeruginosa (associated with hot tubs and wet suits) [6], Ma‐
lassezia furfur, herpes simplex virus, varicella-zoster virus and Demodex mites. Non-infec‐
tious folliculitis include eosinophilic folliculitis thought to be an autoimmune process
directed against the sebocytes [7] and a papulopustular follicular eruption after treatment
with epidermal growth factor receptor (EGF-R) inhibitors [8].
2.2.2. Treatment
Uncomplicated superficial folliculitis may respond to improved hygiene supported by use
of antibacterial soap. If this simple measure is not sufficient, topical antibiotic cream can be
used. Refractory or deep infections may require administration of systemic antibiotics. Selec‐
tion of appropriate antibiotic is based on knowledge of the common microorganisms in‐
volved in the particular type of infection before results of microbiology examination and
antibiotic sensitivity tests are available. Herpetic folliculitis responds to oral antivirals (e.g.
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valaciclovir). Eosinophilic folliculitis may respond to isotretinoin, metronidazole, UV-B pho‐
totherapy, indometacin or itraconazole [1]. Infectious folliculitis may progress to involve
deeper layer of the dermis and finally spread to subcutaneous tissue.
2.3. Furuncle and carbuncle
Furuncle is purulent infection involving the hair follicle and extending to surrounding sub‐
cutaneous tissue. (Figure 3)
Figure 3. Furuncle of the upper lip. Note progression of infection to right paranasal area.
Furuncles can occur anywhere on hairy skin. A carbuncle is the coalescence of several furun‐
cles with pus draining from multiple follicular orifices. Carbuncles frequently develop on
the nape and are more likely to be seen in diabetic patients [3]. In immunocompetent indi‐
viduals, furuncles and carbuncles are usually caused by S. aureus. (Figure 4)
Figure 4. Carbucle of right cheek in an immunocompetent patient.
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2.3.1. Clinical presentation
In the face, furuncles are frequently seen on the chin, upper lip and paranasal area. Each le‐
sion consists of an inflammatory nodule and an overlying pustule through which hair
emerges. Furuncles of the nasal vestibule can be insidious and not obvious upon cursory ex‐
amination and their symptoms, namely swelling of upper lip and infiltrate of upper oral
vestibule, can lead to false impression of odontogenic infection. In patients affected by a fa‐
cial furuncle, fever and malaise are common. Lesions are extremely painful and they are sur‐
rounded by area of cellulitis and collateral edema. (Figure 5)
Figure 5. Furuncle of the nasal vestibule referred with suspicion of an odontogenic abscess.
2.3.2. Treatment
Small furuncles may burst and heal spontaneously [1]. Application of moist hot dressing can
promote drainage. Also gentle removal of overlying crust and necrotic central plug can be
helpful; however attempts to express purulent content should be discouraged. Conservative
management is preferable and only rarely cases of furuncles or carbuncles progressing into
subcutaneous abscess require incision and drainage. In the face, whenever possible, this
should be done through intraoral route to avoid facial scarring. Systemic antibiotics are nec‐
essary in instances of substantial collateral cellulitis, alteration of general condition and
signs of developing facial thrombophlebitis. This initial empirical therapy should be aimed
at supposed staphylococcal etiology. Until recently, staphylococcal infections acquired out‐
side of the healthcare setting have been frequently methicillin-sensitive and responsive to a
wide range of antibiotics. Since 1980, methicillin-resistent staphylococcus aureus (MRSA) in‐
fections have been reported in community outbreaks. These organisms have been called
community-acquired or community-associated MRSA, as opposed to hospital acquired
MRSA [9]. Hospital acquired MRSA is usually resistant to at least three β-lactam antibiotics
and is usually susceptible only to vancomycin, sulfamethoxazole, and nitrofurantoin. Com‐
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munity acquired MRSA is more likely to be susceptible to clindamycin and has varying sus‐
ceptibility to tetracycline, fluoroquinolone, erythromycin and vancomycin [10].Outbreaks of
furunculosis may occur in families and other groups involved in close personal contact, like
prisoners, members of sports teams or outdoor recreation groups [3,11]. Inadequate person‐
al hygiene and exposure to others with furuncles play important role. Control of outbreaks
may require bathing with antibacterial soaps, thorough laundering of clothing, towels, bed
spreads, separate use of towels and washcloths. Eradication of staphylococcal carriage
among colonized persons should be attempted. The prevalence of nasal staphylococcal colo‐
nization in the general population is 20–40%, but not all carriers develop recurrent skin in‐
fections. Eradication of nasal colonization can be achieved by application of mupirocin
ointment twice daily in the anterior nares for the first 5 days each month [12].
2.4. Cellulitis
Cellulitis is diffusely spreading soft tissue infection not associated with underlying suppura‐
tive foci. It involves rapidly spreading areas of edema, erythema, and may be accompanied
by lymphangitis and regional lymphadenitis [13].
2.4.1. Clinical presentation
In orofacial areas cellulitis is routinely seen as an early stage of odontogenic infections and it
is present also at the periphery of other defined skin infections and infected traumatic
wounds (Figure 6).
Figure 6. Nonodontogenic facial cellulitis following expression of comedones.
It can also occur as disease per se when organisms enter through breaches in the skin. The
breaks in the skin can be small and clinically inconspicuous. Predisposing factors for these
infections include conditions that make the skin more fragile or local host defenses less ef‐
fective, such as obesity, previous cutaneous cuts, venous insufficiency, lymphatic obstruc‐
tion or other causes [3].Cellulitis of non-odontogenic origin is most commonly caused by β-
hemolytic streptococci (usually group A) but may also be caused by other streptococcal
species. Less frequently, S. aureus may be involved, especially in cases involving penetrating
trauma. An etiologic diagnosis of simple cellulitis is frequently difficult and generally un‐
necessary for patients with mild signs and symptoms [3].
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2.4.2. Treatment
Antibiotic treatment alone is effective in most patients with simple cellulitis. Therapy should
include an antibiotic active against streptococci. A large percentage of patients can receive
oral medications. Suitable agents include dicloxacillin, cephalexin, clindamycin, or erythro‐
mycin. Parenteral therapy is indicated for severely ill patients or for those unable to tolerate
oral medications. Reasonable choices include a penicillinase-resistant penicillin such as naf‐
cillin, a first-generation cephalosporin such as cefazolin, or clindamycin or vancomycin for
patients with penicillin allergies [3]. In cases of uncomplicated cellulitis, 5 days of antibiotic
treatment is as effective as a 10-day course [14].
2.5. Erysipelas
Erysipelas is a well-demarcated, painful skin infection characterized by intense erythema. It
is almost always caused by β-hemolytic streptococci. The term erysipelas is often used in‐
consistently and some physicians use it to describe simple cellulitis. The distinction between
these two terms relates to the depth of inflammation; erysipelas affects the upper dermis, in‐
cluding the superficial lymphatics, whereas cellulitis involves the deeper dermis and subcu‐
taneous fat. In practice however, distinguishing between cellulitis and erysipelas clinically
may be difficult [3].
2.5.1. Clinical presentation
Erysipelas is distinguished clinically from other forms of cutaneous infection by the follow‐
ing two features: The lesions are raised above the level of the surrounding skin, and there is
a clear line of demarcation between involved and uninvolved tissue [15]. (Figure 7)
Figure 7. Facial erysipelas.
The skin surface may resemble an orange peel because superficial cutaneous edema sur‐
rounds the hair follicles, which causes dimpling. Vesicles, bullae, and cutaneous hemor‐
rhage in the form of petechiae or ecchymoses may develop. Systemic manifestations like
fever, tachycardia, hypotension, and leukocytosis may occur, even before the skin abnormal‐
ities appear. In older textbooks, pictures of erysipelas of the face characteristically involved
the butterfly area, which is nowadays rarely seen.
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2.5.2. Treatment
The first-line treatment of erysipelas is intravenous benzyl-penicillin. In penicillin allergic
patients, clindamycin may be used. Anti-staphylococcal drugs are considered if patients fail
to improve or have features suggestive of staphylococcal infection like bullous eruptions [1].
2.6. Craniofacial necrotizing fasciitis
Necrotizing fasciitis (NF) is rapidly progressing bacterial infection spreading along the deep
fascial planes with relative sparing of skin and underlying muscles [16]. Necrotizing infec‐
tion may involve any combination of dermis, subcutaneous tissue, fascia or muscle. Blood
supply to the fascia is typically more tenuous than that of muscle or healthy skin, making
the fascia more vulnerable to infectious processes. Additionally, the propensity for fluid col‐
lection between involved fascia and adjacent tissues further weakens fascial immune protec‐
tion [9]. The incidence of NF increases with age and most adult cases occur in patients with
underlying chronic illness like diabetes, alcohol/drug abuse, immunosuppression, malig‐
nancy or chronic systemic diseases. Most patients with NF have polymicrobial infections
with an average of 4.4 organisms isolated per infection [17,18]. Although these polymicrobi‐
al infections can spread widely and become life-threatening, they tend to be less aggressive
than infections caused by a limited number of highly virulent pathogens. These may cause
very rapidly spreading necrotizing infections in an immunologically intact host through
production of exotoxins. Such pathogens most commonly include S. pyogenes (group A he‐
molytic streptococcus), group B streptococcus, community acquired MRSA, and Clostridium
spp [9].Involvement of the head and neck is rare. Only 67 cases were reported between 1945
and 1990. Recently, increased awareness of the condition resulted in more reports of cervico-
facial NF appearing in the literature. Cervico-facial NF can be divided into two groups: cer‐
vical and craniofacial. Cervical NF is characterized more frequently by polybacterial
etiology, mainly odontogenic source of infection, predominance of males and higher mortal‐
ity. Craniofacial NF does not have gender preference, has lower mortality, but cosmetic and
functional consequences are often severe.
2.6.1. Clinical presentation
Craniofacial NF predominantly originates from periorbital regions;d only one microorgan‐
ism is usually identified from cultures, most commonly group A hemolytic streptococci. Ini‐
tial symptoms may resemble simple cellulitis or erysipelas. The distinguishing features are
fast progression, pain disproportionate to clinical findings, systemic toxicity and presence of
gas. Gas is best detected by CT scan. Fully developed specific clinical picture includes ede‐
ma that extends beyond skin erythema, cutaneous anesthesia, skin ecchymosis that precedes
skin necrosis and presence of bullae [8].
2.6.2. Treatment
The promptness of initial surgical debridement is considered decisive for favorable outcome
[19,20]. Patients treated surgically on the day of admission have distinctively better progno‐
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sis. The early incision and debridement of all involved spaces can salvage the skin, which
later in the progress of disease succumbs to necrosis due to thrombosis of feeding vessels.
All necrotic tissues should be excised, the defects should be kept open and debridement
should be repeated until a completely healthy granulating wound is obtained. While the
surgical treatment should be performed promptly, it cannot be as aggressive as in the ex‐
tremities and trunk, where large areas of skin and subcutaneous tissue are often sacrificed. It
is necessary to preserve as much of the anatomic structures as possible to avoid significant
cosmetic disfigurement and functional limitations. Simultaneous immediate antibiotic thera‐
py should consist of high-dose penicillin G or ceftriaxone in addition to metronidazole and
clindamycin for anaerobic coverage. Clindamycin is a potent suppressor of bacterial toxin
synthesis, facilitates phagocytosis of S. pyogenes by inhibiting M-protein synthesis and caus‐
es suppression of lipopolysaccharide-induced monocyte synthesis of TNF-α [21]. Numerous
recent published reports claim substantial reduction in mortality and length of hospital stay
when hyperbaric oxygenotherapy is used as adjunctive treatment [22].
3. Infected tissue fillers
Injectable soft tissue fillers (ISTFs) are widely popular in facial rejuvenation. ISTFs are usual‐
ly injected into the deep dermis or dermal – subdermal junction for wrinkles, skin creases or
depressed scars [23]. Recently there is a tendency to more frequent use of fillers injected into
deep subcutaneous layers for augmentation [24]. ISTFs are effective in treating volume loss
and soft tissue redistribution [25].
3.1. Tissue fillers
All ISTFs with exception of autologous fat are foreign alloplasts. Host tissue response to
their presence depends on material type [26]. They can be differentiated as volumetric and
structural, or fibroplastic, based on the biomechanics of filling effect [27]. Another practical‐
ly important property is their time of tissue survival differentiating them into temporary,
long lasting or semi-permanent and permanent (Table 1).
The most commonly used ISTFs are homogenous polymer gels, both degradable and nonde‐
gradable. They are volumetric; the filling effect stems from the gel itself. Common represen‐
tatives of degradable homogenous ISTFs are hyaluronic acid and collagen. They are
hydrophilic and closely resemble substances normally present in tissues. Both are degraded
by naturally occurring enzymes. Nondegradable homogenous ISTFs are represented by polya‐
crylamide hydrogel and silicone gel. Polyacrylamide gel is hydrophilic, consisting of polya‐
crylamide, to which water molecules are loosely attached. These water molecules are readily
exchanged with those of the surrounding tissue. The macrophages enter the gel, become
transformed into fibroblasts that connect and eventually form a vascular fibrous network.
Polyacrylamide hydrogel is widely resistant to degradation and phagocytosis [26]. Silicone
gel differs from the other polymer gels by being hydrophobic, which results in dispersion in
the tissue in the form of rounded vacuoles or droplets, which do not interact with the host
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tissue. However they stimulate response of macrophages and foreign body giant cells and
are frequently seen within these cells as small round inclusions. Combination or structural
ISTFs are composed of two components: Solid microparticles dissolved in a transient carrier
gel. Microparticles remain in the tissue after the carrier gel has been degraded and thus, elic‐
it a foreign-body reaction, which results in fibrosis responsible for the final filling effect.
Some of the microparticles are nondegradable and add to the resulting filling effect, others
are slowly degraded over a period of several years [26].
Category Brand name Description Duration
Collagen Zyderm Highly purified bovine dermal collagen in a phosphate-buffered physio‐logical saline containing 0.3% lidocaine 2-4 months
Zyplast Highly purified bovine dermal collagen cross-linked with glutaraldehydein a phosphate-buffered physiological saline containing 0.3% lidocaine 3-6 months
Cosmoderm Highly purified human-based collagen in a phosphate-buffered physio‐logical saline containing 0.3% lidocaine 3-6 months
Cosmoplast Highly purified human-based collagen cross-linked with glutaraldehydein a phosphate-buffered physiological saline containing 0.3% lidocaine 3-4 months
HA deriva‐
tives Hylaform HA of rooster combs, 500µ particles, 20 % cross-linked 3-6 months
Restylane HA from S. equi, cross-linked with BDDE; NASHA; 400 μ gel particles, 1%cross-linked 6 months
Perlane HA from S. equi, cross-linked with BDDE; NASHA; 940-1090 μ gel parti‐cles 6-12 month
Juvederm HA from S. equi cross-linked with BDDE in homogenized gel 3-6 months
Prevelle Silk HA from S. equi cross-linked with 0.3% lidocainein homogenized gel 2-3 months
CHA deriva‐
tives Radiesse
CHA microspheres 25-45 μ in a gel of water, glycerin, and sodium car‐
boxymethylcellulose 1-2 years
PLL deriva‐
tives Sculptra
Poly-L-lactic acid mixed with mannitol and sodium carboxymethylcellu‐
lose 1-2 years
PMM deriva‐
tives Artefill
PMM microspheres 30-50 μ in water-based gel of 3.5% bovine collagen,
0.3% lidocaine, phosphate buffer, and 0.9% NaC Permanent
Silicone Silikon 1000 Purified polydimethylsiloxane Permanent
Hydrogels Aquamid 97.5% apyrogenic water and 2.5% polyacrylamide Permanent
Bio-Alcamid 96% apyrogenic water and 4% polyalkylimide Permanent
Autogenous
fat -
Hand –held syringe aspirate, usually from hips or abdomen, sedimented
or centrifuged
Semi-perma‐
nent
Table 1. Overview of ISTFs. HA = hyaluronic acid, CHA = Calcium hydroxylapatite, BDDE = butanediol diglycidyl ether,
NASHA = nonanimal stabilized hyaluronic acid, PLL = Poly-L-lactic acid, PMM = polymethylmetacrylate
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3.2. Complications of tissue fillers
Complications can be attributed to the product properties,  method of delivery and reac‐
tion of the recipient's immune system. It is convenient to divide complications according
to  the  time  of  onset.  Immediate  complications  are  usually  related  to  faulty  application.
They  include  palpable  or  visible  implants  due  to  superficial  injection,  uneven  distribu‐
tion,  overcorrection,  undercorrection  and  hypersensitivity.  The  most  serious  immediate
complication is vascular compromise by mechanism of either direct arterial embolization
of  filler  or  local  overfilling leading to venous compression in the treated area [28].Early
onset complications  appear between 2 – 3 days or weeks after injection. Early non-inflam‐
matory  nodules  are  localized  accumulations  of  filler  material.  Early  inflammatory  nod‐
ules  are  red,  painful  and  should  be  treated  as  infections.  If  there  is  any  fluctuation  or
impending skin erosion, incision and drainage with culture should be performed. Empir‐
ic antibiotic treatment should begin with a macrolide or tetracycline and should be con‐
tinued  for  4  to  6  weeks  [29].  Late  (several  weeks  to  1  year)  or  delayed  (>1  year)
complications  usually present as nodules or subdermal masses. Stimulatory fillers such as
polylactic acid and calcium hydroxylapatite, or silicone may give rise to fibrotic nodules.
Immune response to filler material or chronic infection can lead to formation of granulo‐
mas [30-34]. They should be treated as foreign body infections with macrolide or tetracy‐
cline,  and  strong  consideration  should  be  given  to  two-drug  therapy.  If  there  is  no
response in  7  to  10  days,  intralesional  corticosteroids  can be injected while  maintaining
the patient on oral antibiotics [29].  Infrequent but the most serious late complications of
ISTF present themselves as acute facial cellulitis or abscess.
3.3. Role of biofilms
Delayed complications of ISTFs have been attributed to biofilms [35]. Biofilms are defined as
a structured community of microorganisms encapsulated within a self-developed polymeric
matrix and irreversibly adherent to a living or inert surface [36]. They are also often charac‐
terized by structural heterogeneity, genetic diversity and complex community interactions.
They respond to stimuli, grow and maintain a homeostatic environment. Extracellular poly‐
meric matrix of biofilms may interfere with macrophage phagocytosis and allow for easier
exchange of extrachromosomal DNA plasmids encoding antimicrobial resistance. All surgi‐
cal implants like orthopedic appliances, heart valves, indwelling catheters, stents or other
forms of foreign material may be compromised by biofilms. Active clinical infections can
flare up weeks, months and even years after initial surgery. Bacteriemia caused by dental
treatment, contaminated surgery, or trauma can activate infective response of a chronic bio‐
film. Once the biofilm has been activated, it leads to acute purulent infection. The active in‐
fection can be controlled with antibiotic therapy, but the underlying biofilm can persist and
generate a recurrence [27,37,38]. The biofilm theory remains a popular explanation for late
infectious complications of ISTFs; but it has been recently challenged and requires further
proof [39].
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3.4. Clinical presentation and diagnosis
Acute purulent inflammation caused by infected facial ISTF closely resembles acute odonto‐
genic infection: it causes painful facial swelling, redness, extensive collateral edema and pal‐
pable in-depth fluctuation. Deep buccal space and periorbital region are most frequently
involved. The general condition is usually altered by fever, malaise and pain. Laboratory
sings of acute bacterial infection are present. However, intraoral clinical and x-ray examina‐
tion fails to discover an odontogenic source of infection, and even if possible odontogenic
infectious focus is identified, typical signs of acute odontogenic infection, such as oral vesti‐
bule swelling and redness, tooth mobility, or sensitivity to axial percussion are missing [40].
(Figure 8)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. A. 32y old female underwent cheek augmentation by injections of unknown substance in a cosmetic salon 3
years earlier. One week before admission she underwent another injection in periorbital areas. B. Foreign glue-like
material with blood admixture drained from the right buccal space. C.Large amount of foreign material mixed with
sanguinopurulent exudate drained from the left buccal space. D. Sonography (US) of left cheek. E. US of right cheek;
note hypoechogenic loci with scattered hyperechogenic foci of foreign material in the subcutaneous layer.
Many patients fail to report filler injections on initial interview because they do not con‐
sider them as medical procedures or are embarrassed[41,42]. Patients with acute facial in‐
fections of uncertain origin should therefore be specifically questioned about a history of
cosmetic procedures. Despite of it, some patients will admit application of ISTF only lat‐
er, when they are confronted with finding of foreign material in a drained exudate.Ultra‐
sound  (US)  examination  can  be  helpful  in  establishing  the  presence  of  ISTF  and  its
precise location [41,42].  CT imaging may be indicated if  there is a suspicion of infection
spread, especially orbital cellulitis.
3.4.1. Treatment
Treatment should follow established principles of dealing with acute purulent infection i.e.
eliminate source of infection, drain involved anatomical spaces and provide antibiotic and
supportive therapy. When ISTF becomes infected, antibiotic treatment can only mitigate the
process and sooner or later after discontinuation of medication recurrence is inevitable. It is
therefore necessary to remove all infected material, which is usually identical with drainage
of involved spaces. Only small amounts of ISTFs can be removed by aspiration [43], thus in
cases of deep abscesses incision and drainage is the treatment of choice. To avoid facial scar‐
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ring, intraoral incision is the preferred route. More than one deposit of filler material can be
present in any treated area and while one focus is drained another one can remain dormant
and consequently undetected on clinical examination. This can lead to recurrence [40]. Char‐
acteristic histopathologic findings allow the identification of the specific filler agent. This
can be important especially in litigation cases where a number of different fillers have been
injected in the same site over the time, or where patients had not been correctly informed
about fillers and potential risks [44].
4. Cervico-facial lymphadenitis
A disease process involving lymph nodes (LNs) is referred to as lymphadenopathy. Lym‐
phadenopathies have multiple etiologies, the most common of which are infection, neopla‐
sia and autoimmune diseases. Inflammation of LN is known as lymphadenitis. The
lymphatic system of the cervicofacial region serves as the initial line of defense against infec‐
tions of all structures within the head, neck, and upper respiratory tract [45].
4.1. Anatomy and pathophysiology
Diagnosis of the lymphatic infections must be based on the knowledge of anatomic location
of LNs, the area and the pattern of lymphatic drainage, and their defense mechanism
[45,46]. The lymphatic system of the head and neck contains about 300 nodes, and the extra‐
nodal lymphatics of the palatine, pharyngeal and lingual tonsils are known as the lymphatic
ring of Waldayer. All the lymphatics from the head and neck drain into the deep cervical
LNs [47]. Superficial nodal enlargement usually reflects invasion through an epithelial sur‐
face (e.g. skin, oral mucosa), whereas deep nodal enlargement results from an infectious
process involving more central structures (e.g. middle ear, posterior pharynx).[45] Lymph
nodes contain T- and B-lymphocytes as well as antigen-presenting macrophages (dendritic
cells). Tissue lymph enters the LN via one or more afferent vessels and percolates through a
series of reticuloendothelial-lined channels that coalesce and drain through an efferent lym‐
phatic vessel. [45] Once infection occurs, a series of LN reactions follow according to the
type and nature of the infectious agent. These will result into signs and symptoms with pre‐
sentation, which can be acute, subacute, or chronic and can be localized or generalized. In‐
fection of the LNs of the orofacial region can be bacterial, viral, protozoal or fungal. The
most common pathogens causing lymphadenitis in the orofacial region include bacterial
pathogens as S. aureus, S. pyogenes, Bartonella Henselae, Francisella tularensis, Treponema pallid‐
um, as well as tuberculous and non-tuberculous Mycobacteria. Many cases of cervical aden‐
opathy associated with viral illnesses are due to reactive hyperplasia. Causes of the
associated upper respiratory tract infection include rhinovirus, parainfluenza virus, influen‐
za virus, respiratory syncytial virus, coronavirus, adenovirus, and rheovirus. Other common
viral etiologies include cytomegalovirus and Epstein-Barr virus. Less frequent etiologies in‐
clude mumps, measles, rubella, varicella, herpes simplex, human herpes virus 6 (roseola),
and coxsackie viruses. Approximately 10% of patients with acquired infections due to Toxo‐
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plasma gondii also present with cervical lymphonoditis. Fungal infections of orofacial LNs
are mentioned later.
4.2. Acute bacterial lymphadenitis
Most cases of acute bacterial lymphadenitis occurs in children aged 1 to 4 years. Forty per‐
cent to 80% of cases in this age group are due to S. aureus or Strep. pyogenes. Lymphadenitis
due to Stepr. pyogenes should be suspected if the patient presents with the typical vesicular,
pustular, or crusted lesions of impetigo involving the face or scalp. The most commonly in‐
volved LNs in decreasing order of frequency are the submandibular, upper cervical, sub‐
mental, occipital, and lower cervical nodes. [45]
4.2.1. Clinical presentation and diagnosis
Patients typically present with concomitant pharyngitis, tonsillitis, acute otitis media, or im‐
petigo. Acute cervical lymphadenitis can also occur following animal bites or scratches.
However, there may be a time gap between initial infection at the site of entry and lympha‐
denitis. LNs enlargement is mostly unilateral, associated with systemic manifestations, such
as fever, and malaise. Infected LNs tend to be quite tender with collateral cellulitis and ede‐
ma. Erythema and increased temperature of the overlying skin are signs of impending lique‐
faction. Diagnosis is usually based on the clinical picture. Laboratory tests are nonspecific
and seldom required. In contrast, laboratory evaluation plays a crucial role in determining
the etiology of subacute, chronic, and generalized lymphadenopathy.
4.2.2. Treatment
Because staphylococci and streptococci are the most common pathogens, initial therapy usu‐
ally includes a β-lactamase resistant antibiotic; this agent is used because of the high inci‐
dence of penicillin resistance in isolated staphylococci. Other treatment options include
cephalexin, oxacillin, or clindamycin. Very young patients or patients with severe symptoms
may require hospitalization for initiation of parenteral antibiotic therapy and close observa‐
tion. For older patients with dental or periodontal disease, the antibiotic regimen should in‐
clude coverage for anaerobic oral flora (i.e., penicillin V or clindamycin). Reports from
multiple centers have documented an increasing frequency of community-acquired methi‐
cillin-resistant S. aureus (CA-MRSA) skin and soft tissue infections, including lymphadenitis.
Failure to respond to appropriate first-line antibiotic therapy should prompt consideration
of expanding coverage to include methicillin-resistant strains of S. aureus. [45] Therapy is
usually administered for 10 days and continued for at least 5 days beyond resolution of
acute signs and symptoms. If a primary site is identified, cultures should be obtained and
treatment directed to that site as well. There should be marked clinical improvement after 2
to 3 days of therapy, although complete resolution of nodal enlargement may require sever‐
al weeks [45].If there is no response to conservative therapy, an attempt to identify etiologic
agent can be done by fine needle aspiration (FNA) under US control. The aspiration of an
affected node is successful in 60% to 88% of cases [46]. Fluctuance develops in about 25% of
patients. Adequate drainage should be ascertained by incision under GA and no loculations
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or pockets of pus left behind. Specimens of pus should be sent for Gram stain, aerobic and
anaerobic cultures, as well as for acid-fast stains and mycobacterial culture. In immunocom‐
promised patients also KOH preparation, fungal cultures and tissue biopsy should be con‐
sidered. (Figure 9)
 
 
 
 
 
 
 
Figure 9. A. Abscessed submandibular lymph node in 4y old boy with a 10-day history of submandibular swelling
treated by amoxicillin. Infection source was not indentified. B. Culture of drained pus yielded S. aureus.
Drainage should be maintained by insertion of drains (e.g. Penrose or corrugated rubber
drain), left in place for 2-3 days. Dressings are changed whenever it becomes saturated by
exudate. Antibiotic therapy can be discontinued as soon as clinical improvement is obvious.
4.3. Cat scratch disease
Cat scratch disease (CSD) follows inoculation of Bartonella Henselae through broken skin or
mucous membranes. B. Henselae is a small, pleomorphic gram negative bacillus. The reser‐
voir for B. Henselae is the domestic cat and 1/3 of cats or more are infected. Cat fleas become
infected and replicate B. Henselae following ingestion of blood from an infected cat. Experi‐
mentally, B. Henselae was transmitted by transferring fleas from bacteremic cats to specific
pathogen-free cats. In another experiment, cats have been infected with B. henselae by intra‐
dermal inoculation of feces derived from infected fleas. Although the exact mode of trans‐
mission of B. henselae to humans remains unclear, contamination of the claws or teeth with
infected flea feces may be required for transmission. [47]
4.3.1. Clinical presentation and diagnosis
CSD presents as regional lymphadenitis associated with a characteristic skin lesion at the
site of inoculation. An erythematous skin papule or pustule typically develops 3-10 days af‐
ter contact with an infected cat (scratch, bite or lick). The patient may suffer low-grade fever
and malaise, anorexia, headache and splenomegaly. Regional lymphadenitis develops 5
days to 2 months later. Often the primary site of involvement has resolved by the time lym‐
phadenopathy is noted. The most common sites of lymphadenopathy are the axilla (52%)
and the neck (28%). Patients usually present with a single large tender node. Involved LNs
undergo sequential changes of lymphoid hyperplasia, granuloma formation, microabscess
development, and in some cases suppuration. The most common atypical presentation of
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CSD is Parinaud’s oculoglandular syndrome (POS). This occurs in up to 17% of CSD pa‐
tients due to autoinoculation of the eye by rubbing it with their hands after cat contact. POS
is manifested either as conjunctivitis with parotid swelling caused by intraparotid lympha‐
denitis or as an ocular granuloma. Diagnosis of CSD has traditionally required the presence
of 3 of 4 criteria: Contact with a cat resulting in a primary lesion, regional lymphadenopathy
in the absence of other causes of lymphadenopathy, a positive skin test, and the presence of
characteristic histopathological features. The CSD skin test is performed by intradermal in‐
jection of heat-inactivated material obtained from a node of a patient fulfilling the diagnostic
criteria of the disease. Because of safety concerns about the use of human-derived reagents
and the lack of widespread availability, serologic testing for antibodies to B. henselae is con‐
sidered a suitable alternative to skin testing. Aspirate from lymph node contains no bacteria
that can be cultured by routine methods. Isolation of Bartonella is typically time-consuming,
often requiring a 2- to 6-week or longer incubation for primary isolation. The resulting iso‐
late must then be identified by biochemical or genetic methods. [48]
4.3.2. Treatment
The disease is usually self-limited. Treatment is mainly supportive, with reassurance, hot
moist compresses and analgesics. It may be necessary to aspirate pus or surgically remove
an excessively large lymph node. Benefits of antibiotic therapy is doubtful. Azithromycin
has been shown to be associated with more rapid resolution of nodal enlargement. Tetracy‐
cline or erythromycin therapy may also be helpful. [49]
4.4. Tularemia
Tularemia  is  a  highly  contagious  disease  caused  by  Francisella  tularensis,  a  fastidious
gram-negative  coccobacillus,  characteristically  isolated  as  small,  poorly  staining  gram-
negative rods seen mostly as single cells.  Francisella  tularensis  is  maintained in the envi‐
ronment  by  various  terrestrial  and  aquatic  mammals  such  as  ground squirrels,  rabbits,
hares,  voles,  muskrats,  water  rats,  and  other  rodents.  In  many  parts  of  the  world,  the
disease  caused  by  F.  tularensis  is  known  under  colloquial  names  such  as  rabbit  fever,
hare  fever,  deerfly  fever,  and  lemming  fever.  A  wide  range  of  arthropod vectors  have
been  implicated  in  the  transmission  of  tularemia  between  mammalian  hosts,  specially
ticks, biting flies and mosquitoes. [51]
4.4.1. Clinical presentation and diagnosis
Tularemia in humans can occur in several forms, depending to a large extent on the route of
entry. Many cases of disease caused by lower-virulence strains are undiagnosed. The most
common form of the disease is ulcero-glandular tularemia, which usually occurs as a conse‐
quence of a bite from an infected arthropod vector. After an incubation period of 3 to 5 days,
the patient experiences the sudden onset of flu-like symptoms, especially chills, fever, head‐
ache, and generalized aches. An ulcer forms at the site of infection. Bacteria are disseminat‐
ed from this site via the lymphatic system to regional LNs. The enlargement of these LNs
often resembles the classical bubo associated with bubonic plague. During early bacteremic
A Textbook of Advanced Oral and Maxillofacial Surgery82
phase of the infectious bacteria may be disseminated also to other tissues such as the spleen,
liver, lungs, kidneys, intestine, central nervous system, and skeletal muscles. A rare varia‐
tion of ulcero-glandular disease is oculo-glandular tularemia, where the conjunctiva is the
initial site of infection, usually as a result of the transfer of bacteria on the fingertips. The
disease is marked by the appearance of ulcers and nodules on the conjunctiva, and without
treatment the infection spreads to the regional LNs. The ingestion of infected food or of bac‐
teria in drinking water can result in oropharyngeal tularemia, characterized by sore throat
with enlargement of the tonsils and the formation of a yellow-white pseudo membrane, ac‐
companied by swollen cervical LNs. Other, more serious clinical forms of disease are gastro‐
intestinal and pneumonic tularemia. Isolation of bacteria from clinical specimens is possible;
however, it needs a special culturing technique. Because of the difficulty in culturing F. tu‐
larensis, most cases of tularemia are diagnosed on the basis of clinical picture and/or serolo‐
gy. The detection of serum antibodies is most frequently achieved by agglutination or an
ELISA. [51]
4.4.2. Treatment
The drugs of choice for the treatment of tularemia include streptomycin, gentamicin and ci‐
profloxacin. Ciprofloxacin was the antibiotic with the lowest level of therapeutic failure and
with the fewest side effects and was also shown to be suitable for children and in a case
where relapse was evident after initial gentamicin therapy [52].
4.5. Syphilis
Syphilis is a sexually transmitted disease caused by infection with Treponema pallidum, a
Gram-negative bacterium, which is an obligate internal parasite of spiral shape. Natural in‐
fection with T. pallidum is limited to the human host and is usually transmitted by sexual
contact; the infectious lesion is on the skin or mucous membrane. Treponema pallidum rapidly
penetrates intact mucous membranes or microscopic dermal abrasions and, within a few
hours, enters the lymphatics and blood to produce systemic infection. The disease progress‐
es in a series of overlapping stages: primary, secondary, latent, and tertiary. Disease trans‐
mission between mother and child in utero results in congenital syphilis. [53]
4.5.1. Clinical presentation and diagnosis
Incubation time from exposure to development of primary lesions at the site of inoculation
averages 3 weeks but can range from 10-90 days. A papule develops at the site of infection
and breaks down to form an ulcer - chancre. The lesion is usually singular, painless, with
base infiltration and hardened high margins. After the appearance of the chancre, regional
lymphadenopathy occurs. Secondary syphilis develops about 4-10 weeks after the appear‐
ance of the primary lesion. Systemic manifestations include malaise, fever, myalgias, arthral‐
gias, lymphadenopathy, and rash. Widespread mucocutaneous lesions are observed over
the entire body and may involve the palms, soles, and oral mucosa. The skin lesions are usu‐
ally macular, discrete, reddish brown, and 5 mm or smaller in diameter; however, they can
be pustular, annular, or scaling. The two principal oral lesions associated with secondary
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syphilis are mucous patches and maculopapular lesions involving the hard palate and mani‐
festing as flat to slightly raised firm red lesions. Of these, wet mucous patches are the most
contagious. Even untreated the patient will eventually lose infectivity and pass into latent
stage. Tertiary syphilis develops 4-8 years later with progressive multi-organ involvement.
The typical tertiary stage lesion is gumma, which in orofacial regions usually involves the
hard palate and tongue. [54,55] Regardless of the stage of disease and location of lesions,
histopathologic hallmarks of syphilis include endarteritis and a plasma cell rich infiltrate.
However, lesional histopathology is not diagnostic. Definitive diagnostic methods are dark
field examination and direct immunoflurescent tests of lesional exudates that detect pres‐
ence of Treponemata, but are applicable only in presence of primary or secondary lesions. Di‐
agnosis is commonly made by serologic testing; however, no one test is sufficient in itself.
The most commonly used screening tests are the Rapid Plasma Reagin (RPR) and the Vene‐
real Disease Research Laboratory (VDRL). These are non-specific, non-treponemal tests that
use reagin, cardiolipin-lecithin-cholesterol antigens to test for antibodies against T. pallidum.
The most specific serologic tests for syphilis are the fluorescent treponemal antibody absor‐
bed assay (FTA.Abs) and the microhemagglutination essay for antibody to T. pallidum
(MHA-TP). These detect antibodies that are produced against treponemal antigens. [54]
4.5.2. Treatment
Parenteral penicillin G is the drug of choice is for all stages of syphilis. Selection of the ap‐
propriate penicillin preparation is important, because T. pallidum can reside in sequestered
sites like CNS and aqueous humor that are poorly accessed by some forms of penicillin. Pen‐
icillin desensitization may be used in patients with known penicillin allergies if necessary.
The Jarisch-Herxheimer reaction is an acute febrile reaction frequently accompanied by
headache, myalgia, fever, and other symptoms that usually occur within the first 24 hours
after the initiation of any therapy for syphilis. Patients should be informed about this possi‐
ble adverse reaction. [56] Studies on the efficacy of ceftriaxone and azithromycin as an alter‐
native for the treatment of syphilis in penicillin allergic patients are presently inconclusive,
and Center for Disease Control (CDC) guidelines neither support nor refute its use. [53]
4.6. Infectious mononucleosis
Infectious mononucleosis (IM), a common cause of cervical lymphadenitis, is caused by Ep‐
stein-Barr virus (EBV), and is its most frequent clinical manifestation. IM is called also “glan‐
dular fever”. EBV is ubiquitous herpes virus associated with nasopharyngeal carcinoma,
Burkitt’s lymphoma, Hodgkin’s disease, and other lymphoproliferative disorders in im‐
mune-deficient individuals. Young children most likely acquire primary EBV infection from
close contact that involves exchange of oral secretions via shared items such as toys, bottles,
and utensils. Before the age of 10, primary infection is usually asymptomatic or produces an
acute illness that is often not recognized as being due to EBV. In adolescents and young
adults, primary EBV infection is acquired chiefly by direct intimate oral contact which al‐
lows for salivary exchange, and frequently presents as IM. That is where another colloquial
name “kissing disease” comes from. Aside from oral transmission, there are reports about
A Textbook of Advanced Oral and Maxillofacial Surgery84
transmission by sexual intercourse, contaminated blood, transplanted hematopoietic cells,
solid organs, or by intrauterine transmission. [57]
4.6.1. Clinical presentation and diagnosis
Infectious mononucleosis most often begins insidiously, with vague malaise, followed sev‐
eral days later by fever, fatigue, sore throat, and swollen posterior cervical lymph nodes.
Some patients experience an abrupt influenza-like onset, with fever, chills, and body aches.
Hepatitis, documented by abnormal liver function tests, is seen in 80% of cases. A useful
clinical clue unique to primary EBV infection is eyelid edema, which gives the patient a slit-
eyed appearance and may be accompanied by facial puffiness. Virtually all patients given
penicillin derivatives develop a rash. Complications include conjunctivitis, hemophagocytic
syndrome, myocarditis, neurologic diseases other than meningoencephalitis, pancreatitis,
parotitis, pericarditis, pneumonitis, psychological disorders, and splenic rupture. [57]The di‐
agnosis of infectious mononucleosis cannot be made on clinical grounds alone. The appro‐
priate laboratory tests include detection of the presence of atypical lymphocytes, Paul-
Bunnel test, monospot test, and detection of EBV antibodies against the viral capsid.
4.6.2. Treatment
The treatment is mainly symptomatic during periods of fever and malaise and includes limi‐
tation of activities, supplementation fluids, nutrition, antipyretics and analgesics. Corticoste‐
roids are indicated for management of complications, such as impending airway
obstruction, autoimmune anemia, and autoimmune thrombocytopenia. A number of antivi‐
ral drugs have been also used with varying degree of efficiency. [58]
4.7. Rubella
Rubella is an acute febrile illness of viral origin characterized by rash and lymphadenopathy
that affects children and young adults. Rubella virus is a member of the Togaviridae family
but in spite of that, it is not transmitted by arthropods. The usual way of transmission is by
droplets from the nose or throat. Rubella is commonly known as German measles or 3-day
measles. [59] Infection during the early pregnancy may result in serious congenital malfor‐
mations and mental disability. Widespread immunization against rubella is critical to pre‐
venting this so called congenital rubella syndrome. [60]
4.7.1. Clinical presentation and diagnosis
Rubella infection begins with low grade fever and swollen, tender lymph nodes, usually in
the back of the neck or behind the ears. Morbilliform rash appears on the face and spreads
downward to the trunk and extremities. As it spreads down, it usually clears on the face.
This rash is often the first sign of illness that a patient or a parent notices. No feature of the
rash is pathognomic and it looks like many other viral rashes. Other symptoms of rubella,
more common in teens and adults, include headache, loss of appetite, mild conjunctivitis
with rhinitis, swollen lymph nodes in other parts of the body, and arthralgia.A clinical diag‐
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nosis of rubella may be difficult, because many exanthematic diseases may mimic rubella in‐
fection. The laboratory diagnosis of rubella can be made either though serologic testing or
by viral culture. The serologic diagnosis consists of demonstrating the presence of rubella-
specific IgM antibody in a single serum sample or observation of a significant (>4-fold) rise
in rubella-specific IgG antibody titers between the acute and convalescent serum specimens
drawn 2-3 weeks apart. The nasopharyngeal or throat swab taken 6 days before and after
onset of rash is a good source of rubella virus that can be cultured and identified. [59]
4.7.2. Treatment
Rubella is mild self-limited illness and no specific treatment is indicated. Maintenance of
good hydration, especially replacement of fluids lost through diarrhea or emesis, is the
mainstay of management. Intravenous rehydration may be necessary if dehydration is se‐
vere. In children and patients with clinical signs of vitamin A deficiency vitamin A supple‐
mentation should be considered. Post exposure prophylaxis should be considered in
unvaccinated contacts. [59]
4.8. Toxoplasmosis
Toxoplasma gondii is a coccidian protozoan of worldwide distribution that can infect a wide
range of animals, birds as well as humans. The cat was identified as the definitive host; how‐
ever T. gondii is unusual in that its propagation does not require passage through the defini‐
tive host (felids in whose intestinal tissues the sexual cycle occurs). About 1/3 of the world’s
human population is estimated to be infected. Humans can be infected from tissue cyst
present in raw or undercooked meat, or from oocysts that are the product of sexual cycle in
cat intestines. Oocysts are very resistant to harsh environmental conditions and are highly
infectious. [61] Avoidance of cats during pregnancy is essential, because of the risk of trans‐
mission to the fetus with serious consequences, especially when transmission occurs in early
pregnancy.
4.8.1. Clinical presentation and diagnosis
Primary infection in the immunocompetent individual is usually asymptomatic. In approxi‐
mately 10% of this patient group, a non-specific and self-limiting illness is manifested most
typically by isolated cervical or occipital lymphadenopathy lasting for less than four to six
weeks. Toxoplasmic lymphadenitis most frequently involves a solitary lymph node without
systemic symptoms or extranodal disease. The lymph nodes are usually discreet, non-ten‐
der, and do not suppurate. Toxoplasmosis can also cause localized lymphadenopathy out‐
side the head and neck areas or generalized lymphadenopathy. After the acute phase,
almost all patients will remain chronically infected with tissue cysts that are dormant and
cause no clinical symptoms. In contrast, toxoplasmosis in patients who are immunocompro‐
mised can be a life-threatening infection. In an immune-deficient patient, the infection can
become acutely disseminated and result in pneumonitis, chorioretinitis and encephalitis.
[62,63]Toxoplasmic lymphadenitis is most often diagnosed by lymph node biopsy and/or se‐
rological assays. Pathological features diagnostic of toxoplasmic lymphadenitis include a re‐
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active follicular hyperplasia, irregular clusters of epithelioid histiocytes encroaching on and
blurring the margins of the germinal centers, and focal distention of sinuses with monocy‐
toid cells. The presence of these histological abnormalities alone, when typical, can suffice
for the diagnosis. However, to increase the diagnostic yield, serological testing (ELISA, PCR,
and IFA) is recommended both in patients with the classical histological features and in
those patients with atypical histological findings. Fine needle aspiration cytology (FNAC) is
rarely useful for the diagnosis, since it allows visualization of only a few isolated cells and
does not permit the evaluation of lymph node architecture. Toxoplasma gondii may be cul‐
tured in the presence of living cells where the typical intracellular and extracellular organ‐
ism can be seen. [63]
4.8.2. Treatment
Acute infection can be treated with a combination of pyrimethamine and sulfadiazine or tri‐
sulfapyrimidines. Treatment with pyrimethamine, sulfadiazine and folinic acid is usually re‐
served for patients who are immunocompromised and those patients who are
immunocompetent but have severe or persistent symptoms. Duration of treatment varies
from 2-4 months depending upon resolution of clinical signs and symptoms. Alternative
drugs include spiramycin, clindamycin, trimethoprime-sulfamethoxazole and various other
sulfonamide drugs. Spiramycin is recommended for use in pregnancy till delivery. [63]
5. Orofacial tuberculosis
Tuberculosis (TB) is chronic granulomatous infection caused by Mycobacterium tuberculosis
or Mycobacterium bovis. TB is one of the most prevalent diseases in the world. In 2010, there
were estimated 12 million prevalent cases (178 cases per 100 000 population) and 1.1 million
deaths worldwide among human immunodeficiency virus (HIV) negative persons. Of the
8.8 million incident cases in 2010, 1.0 million – 1.2 million (12–14%) were among people liv‐
ing with HIV. Approximately 1.4 million people died of TB in 2010. TB is the second leading
cause of death from an infectious disease worldwide, after HIV. Most of the estimated num‐
ber of cases in 2010 occurred in Asia (59%) and Africa (26%). The five countries with the
largest number of incident cases were India, China, South Africa, Indonesia and Pakistan.
The high incidence of TB in developing countries is associated with poor hygiene. [64] Pri‐
mary disease most commonly affects the lungs, with secondary infection to other organs
and tissues, either by hematogenic or lymphatic spread, or by inoculation of infected spu‐
tum. Extrapulmonary TB (EPTB) constitutes 15% to 20% of all cases of TB among immuno‐
competent adults, and it accounts for more than 50% of the cases in HIV positive
individuals. [65] The proportion of EPTB among all TB cases in different parts of the world
has increasing tendency. [66] Most of the extrapulmonary TB infections are secondary. [65]
Head and neck TB is responsible for nearly 10% of all extrapulmonary manifestations of the
disease. [67] Primary infection of orofacial region can happen by droplet transmission from
a TB patient and affect Waldeyer’s ring, with secondary spread to lymphatic nodes. Lymph
nodes of the neck can also be affected by spread from the pulmonary focus via hematoge‐
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nous or lymphatic routes [68]. TB cervical lymphadenitis seems to be the most frequent
manifestation of EPTB in the maxillofacial region [68-71]. Oral mucosa TB is relatively un‐
common. The intact oral mucosa acts as a natural barrier to the mycobacterial invasion be‐
cause of its epithelial thickness, tissue antibodies, oral saprophytes, and salivary enzymes,
as well as cleansing action of the saliva [72]. Oral primary or secondary infection is possible
if natural barrier of healthy mucosa or skin is violated by pre-existing inflammatory process
or trauma. Consumption of infected milk is thought to be an important source of infection of
the oral cavity [68]. Secondary infection by direct inoculation from a pulmonary source to
the larynx, oral cavity and nasopharynx is also possible. Some reports cite oral mucosa [73]
or mandible and adjacent masticatory muscles [74] as the most frequent location of orofacial
TB. Involvement of the temporomandibular joint (TMJ) has been repeatedly reported in re‐
cent years and is considered by some authors as frequently misdiagnosed condition
[67,75-7]. Other infrequent head and neck locations reported have include the eye, ear, sali‐
vary glands, nose, thyroid, nasopharynx, retropharyngeal space and larynx [68,69,71].
5.1. Clinical presentation and diagnosis
Because of frequent absence of classic symptoms associated with pulmonary disease, such as
fever, cough, weight loss, anorexia, and night sweats, diagnosing EPTB can be a clinical
challenge [76]. In the neck, according to ENT literature, the posterior triangle nodes, upper
jugular and supraclavicular nodes are most commonly involved [68-70]. Maxillofacial litera‐
ture describes submandibular and submental nodes as the most often involved lymphatic
nodes [73,74,78]. This discrepancy obviously reflects referral bias. Most patients present
with an isolated discrete node or a collection of matted nodes. Fluctuant mass or draining
sinuses are seen in less than 10% of cases [69,78-9] (Figure 10).
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. A. 35y old male presented with a 6-month history of lasting recurrent abscesses in the left submandibular
area. He was repeatedly prescribed courses of antibiotics without success. B. CT examination revealed multiple en‐
larged lymphatic nodes with signs of liquefaction. C. Aspiration yielded several ml of pus, which was sent for microbi‐
ology examination. Culture results reported presence of Mycobacteriium tuberculosis. D. After 6 months of combined
chemotherapy with INH, rifampicin and ethambutol.
The most frequent locations of oral TB are tongue, vestibular buccal mucosa, gingiva, hard
and soft palate. Sometimes the initial presentation can be non-healing extraction wound. Le‐
sions of the oral cavity usually present as painful ulcer and thus mimic squamous cell carci‐
noma. Most TB lesions are located in the anterior portions of the oral cavity such as the
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buccal mucosa or vestibule area near the corner of the mouth or lower lip; in contrast the
usual location of oral squamous cell carcinoma is on the lateral border of the tongue and ret‐
romolar area [73]. Underlying bone can also get directly infected but TB osteomyelitis is
probably more frequently due to hematogenic spread. The posterior mandible is more com‐
monly involved, especially the ramus of the mandible and the attached musculature. Rich
arterial supply of the masseter and medial pterygoid muscles can play important role as the
lesions are frequently seen to involve the outer cortical plates, whereas the medullary bone
is unaffected [74]. Tuberculosis of TMJ can be a hematogenic infection or develop by pro‐
gression from TB otitis media [68,77]. Presenting clinical features are pain, trismus, and
swelling. Thus, TMJ TB should be considered in the differential diagnosis of patients pre‐
senting with pain and stiffness of the joint [76]. Diagnostic process should begin with imag‐
ing methods depending on a location of the lesion: US and CT with contrast or MRI for neck
lesions, panoramic X-ray and/or CT for facial bone lesions, MRI for evaluation of TMJ. Pa‐
tients suspected of EPTB should have biopsy with acid fast smear, histopathology and cul‐
ture of the lesion, chest radiograph, and sputum culture. While active pulmonary TB occurs
infrequently in immunocompetent patients with EPTB, HIV seropositive patients with nor‐
mal chest films can have active pulmonary TB. Mycobacterial sputum cultures should be
performed in this group of patients regardless of chest film results [79]. FNAC is a minimal‐
ly invasive diagnostic tool and has an established role in the diagnosis of EPTB, including
oral lesions. It is easily performed and can be easily repeated. The complication rate follow‐
ing FNAC is small compared to surgical biopsy. Cytology smears should show the epithe‐
lioid granuloma with or without necrotic material. In patients with equivocal results on
FNAC there may be need for open biopsy when the suspicion of TB is high. Granulomas
with necrosis, which are more specific for TB, are more common in excisional biopsy speci‐
mens compared with FNAC specimens[79]. Patients with lymphatic EPTB show variable re‐
sponse to the tuberculin skin test [78]. The Mantoux test is positive in more than 90% cases
of osteoarticular TB. However, a positive test may also indicate a hypersensitivity reaction
to tuberculin proteins or a previous exposure rather, than active TB infection [76]. The diag‐
nosis of TB in the absence of a positive culture requires a combination of epidemiologic and
histopathologic criteria as well as a trial of antituberculous medication [79].
5.2. Treatment
Conservative therapy with anti-tuberculous drugs (isoniazid, rifampicin, pyrazinamide,
ethambutol and streptomycin) is the mainstay of treatment. In majority of patients the thera‐
py is started based on pathology results while waiting for culture results, which are not
available before 3 weeks. Treatment duration is typically 6 months, and this duration has
been shown to be as effective as regimens of 9–18 months. [79] Adjuvant surgical interven‐
tion can be necessary in cases of TB lymphadenitis with large, matted lymph nodes or fluc‐
tuant, cold abscesses in the neck. However, these nodes often lie adjacent to great vessels
and, if due care is not exercised, injury to great vessels or incomplete excision of the nodes
may occur. TB of the TMJ may require abscess drainage, sequestrotomy or even condylecto‐
my. TB of the facial bones may require sequestrectomy and/or sauceriation. TB of the saliva‐
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ry gland, oral cavity and ear respond very well to antituberculous therapy and do not
require surgical management.
6. Atypical (non-tuberculous) mycobacteriosis
Nontuberculous mycobacteria (NTM) are ubiquitous organisms that typically reside in soil.
They are facultative pathogens and their pathogenicity depends on the interaction between
the microorganism and the host's immune system. About 90% of NTM infections involve the
pulmonary system. Other frequent locations are lymph nodes, skin, soft tissues and bones.
[80] Even less frequent are central nervous system disease, keratitis, and otitis media [81].
The most frequently isolated species is Mycobacterium avium and M. intracellulare (known to‐
gether as M. avium-intracellulare complex), followed by M. scrofulaceum, M. kansasii, M. mal‐
moense, and M. hemophilum. However, a growing number of previously unrecognized slow-
growing mycobacteria have been recently implicated. Some NTM species are ubiquitous
and others have more restricted distribution. Evidence of human-to-human transmission is
lacking.[82-3]
6.1. Clinical presentation and diagnosis
In orofacial region the most prevalent location of infection by NTM are lymphatic nodes.
The disease most commonly affects children with peak incidence at 1-5 years of age [82-4].
The port of entry is probably oropharyngeal mucosa and the lymphatic vessels that drain
the mouth and pharynx. Primary infectious focus can also be facial skin [84]. The disease is
usually unilateral and affects jugulodigastric, submandibular, parotid/pre-auricular, sub‐
mental, and posterior triangle lymph nodes. Most patients are otherwise healthy and a
chronic neck mass that does not respond to antimicrobial therapy is their sole clinical sign.
On average the cervicofacial lymphadenopathy is present for 12 weeks before the proper di‐
agnosis is established and treatment initiated [82]. The size of the infected lymph node can
range from 1 to 6 cm and is typically non-tender. The nodes can occasionally liquefy, which
is accompanied by fixation of overlying skin, violaceous discoloration, parchment-like trans‐
formation of skin and finally formation of draining sinus. In untreated cases, healing usually
occurs by unsightly fibrotic scaring and calcification. (Figure 11)
Contrast-enhanced CT imaging picture characteristic of NTM lymphadenitis is asymmetri‐
cal lymphadenopathy with contiguous, low density ring-enhancement. Inflammatory
changes involving the subcutaneous tissue, such as fat stranding are absent but necrotic foci
within skin and subcutaneous tissue are not uncommon [85]. PPD testing has been shown to
produce variable results. NTM-specific antigen skin testing can be a useful diagnostic meas‐
ure, but it is rarely readily available [82]. Diagnosis depends upon the identification of
NTM. This requires obtaining material for culture. Tissue samples by FNAC or tissue biopsy
are usually necessary, because sampling of draining or ulcerated lesions by swabs do not
provide sufficient diagnostic yield. FNAC is the preferred diagnostic technique for patients
who do not undergo surgical excision. Histological appearance of necrotizing granuloma‐
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tous inflammation with various degrees of caseation is also diagnostic. The most important
differential diagnosis is TB lymphadenitis. [82]
 
 
 
 
 
 
 
 
 
 
Figure 11. A. 36y old man had a 3-month history of lasting submandibular swelling not responding to antibiotic ther‐
apy. FNAC examination gave the result of granulomatous necrotizing lymphadenitis. B. Lymphatic node was extirpat‐
ed under GA. Chest X-ray, PPD test a sputum culture were negative. C. Histopathology examination revealed epithelial
granulomas with giant cells. No fast acid staining organisms were observed. Because lymph node culture also failed,
presumptive diagnosis of NTM infection was made. Patient was lost to further follow-up.
6.2. Treatment
Treatment of uncomplicated NTM lymphadenitis is surgical excision [86-7]. Total excision
should be performed as early as possible to prevent spread and subsequently more difficult
surgery with possible cosmetic consequences. Adjacent normal-appearing enlarged lymph
nodes should also be excised. Curettage might be considered as an alternative in cases of ad‐
herence of the facial nerve branches. Incision and drainage lead to sinus tract formation with
chronic discharge and should be avoided [87]. In a clinical trial including 100 children with
culture or polymerase chain reaction confirmed diagnoses, surgery was more effective than
chemotherapy with cure rates 96% and 66%, respectively. However, for patients with dis‐
charging sinus or proximity of facial nerve branches, chemotherapy can be the preferred
therapeutic modality. Chemotherapy must also be considered for patients in whom surgical
treatment is unsuccessful. Chemotherapy usually includes clarithromycin and rifabutin. [86]
7. Salivary gland infections
Salivary glands (SGs) are exocrine, merocrine glands. Major SGs are the parotid, subman‐
dibular and sublingual. The minor SGs are distributed through the mucosa of the oral cavi‐
ty. While both major and minor SGs can become infected, infection usually affects major
SGs, especially the parotid gland. Infection of SGs can be bacterial, viral, fungal, or as was
recently documented, protozoal.
7.1. Bacterial infections
Bacterial infections of the SGs typically result from retrograde propagation of bacteria
through their ducts from oral cavity. This process is promoted by stasis of salivary flow. [88]
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Predisposing factors for the ductally ascending infection are dehydration, xerogenic drugs
and salivary gland diseases associated with reduced saliva secretion or ductal obstructions.
Other possible modes of infection are through transitory bacteremia, especially in the neona‐
tal period, or direct spread from adjacent infectious processes. [89,90]
7.1.1. Acute bacterial sialadenitis
The parotid gland is the most common site of acute suppurative salivary infection. Saliva of
the parotid gland is primarily serous and therefore provides less protection against ascend‐
ing bacteria. On the other hand, mucoid saliva produced by the submandibular and sublin‐
gual glands contains many antimicrobial protective elements, including lysozymes and IgA
antibodies. Mucins also contain sialic acid, which agglutinates bacteria, preventing its ad‐
herence to host tissues. Specific glycoproteins found in mucins bind epithelial cells, competi‐
tively inhibiting bacterial attachment to these cells. [89] Submandibular sialadenitis is less
frequent and accounts for approximately 10% of all cases of sialadenitis of the major SGs.
Majority of submandibular gland infections is related to sialolithiasis of Wharton’s duct.
Submandibular secretions are more mucinous, and therefore more viscid; they also are more
alkaline, containing a higher percentage of calcium phosphates. These circumstances con‐
tribute to the fact that 85-90% of salivary calculi are located in the submandibular duct. [89]
(Figure 12)
 
 
 
 
 
 
 
Figure 12. A. 40y old female patient presented with painful infiltrate of right sublingual area and trismus. Mucosa of
oral floor was erythematous and right Wharton’s duct orifice discharged pus.B. Occlusal intraoral X-ray film disclosed
presence of 2 sialoliths. These were removed after incision of distal portion of the duct, which was irrigated by saline.
Infection resolved in 1 week.
The most common pathogens associated with acute bacterial infections of SGs are S. aureus
and anaerobic bacteria. The predominant anaerobes include Prevotella and Porphyromonas,
Fusobacterium spp. and Peptostreptococcus spp. Less frequent are streptococci including S.
pneumoniae, and gram-negative organisms, including Escherichia coli, Klebsiella pneumoniae,
and Pseudomonas aeruginosa. [91]
7.1.1.1. Clinical presentation and diagnosis
Local symptoms include a rapid onset of pain, swelling, and induration of the involved
gland. Overlying skin can become purplish as infection progresses. Stensen’s or Wharton’s
ducts may appear erythematous and gentle massage of the gland will frequently result in a
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suppurative discharge from the duct orifice. In submandibular infections, a calculus may be
palpable along the course of Wharton‘s duct. Because of the resistance of the fibrous capsu‐
le, particularly that surrounding the parotid gland, palpation of the abscessed gland may
fail to reveal fluctuance. Systemic manifestations like fever, chills, malaise are frequent. [92]
Laboratory examination revels leukocytosis with neutrophilia. Purulent secretions from
duct orifice should be sent for microbiology examination. CT or US imaging of the gland
may reveal abscess formation; however they are not indicated at the beginning of the dis‐
ease. In the case of submandibular gland infection, orthopantomogram may disclose a sali‐
vary stone. Sialography is contraindicated in the acute phases of sialadenitis because it is
extremely painful and can exacerbate the existing inflammation. [89]
7.1.1.2. Treatment
Elimination of the etiological factor such as ductal obstruction by sialolith is essential. Other
therapeutic measures include proper hydration, stimulation of saliva flow, analgesics and
local heat application to ease the discomfort. Capable patients should be instructed on regu‐
lar external or bimanual massage, starting from the distal bed of the gland and working in
the direction of duct drainage. [92] Initially broad-spectrum antimicrobial therapy is indicat‐
ed to cover all possible aerobic and anaerobic pathogens. Clindamycin, cefoxitin, imipenem,
the combination of metronidazole and macrolide or penicillin plus a β-lactamase inhibitor,
provide adequate coverage. Later the therapy should be guided by results of culture and an‐
tibiotic sensitivity. Presence of methicillin-resistant staphylococci may mandate the use of
vancomycin or linezolid. [90] In most cases of acute submandibular sialadenitis removal of
duct obstruction and conservative therapy are sufficient to resolve the disease. In cases of
acute bacterial parotitis, especially in medically compromised patients like diabetics, infec‐
tion process often reaches the stage of abscess, despite antibiotic treatment. US, CT or MRI
imaging help to recognize this condition. In such instances evacuation of pus becomes nec‐
essary. Small, superficially located abscess can be aspirated. The classical approach to drain‐
age of parotid abscess involves anteriorly based facial flap, and multiple, superficial, radial
incisions in the parotid fascia parallel to the facial nerve branches [89]. Based on our experi‐
ence, we consider such radical surgery unnecessary and impractical, and instead utilize inci‐
sion placed in natural skin crease, as close as possible to the abscess, and dissect bluntly
using fine mosquito forceps (Figure 13).
7.1.2. Chronic bacterial sialadenitis
Like in acute sialadenitis, the causative event in chronic sialadenitis is believed to be a low‐
ered secretion rate with subsequent salivary stasis. This can be due to neglected underlying
obstruction (duct stenosis, stone or foreign body). Another major cause of chronic sialadeni‐
tis is Sjögren’s syndrome. Approximately 2% of patients with Sjögren’s syndrome are affect‐
ed each year [93]. Repeated acute suppurative infections lead over time to permanent
damage characterized by sialectasis, ductal ectasia, and progressive acinar destruction com‐
bined with a lymphocytic infiltrate. The structure of parenchyma and function of the gland
are gradually destroyed. This leads to decrease in salivary secretion and further promotes
Non-Odontogenic Oral and Maxillofacial Infections
http://dx.doi.org/10.5772/54304
93
recurrences in a vicious circle. Some authors feel that chronic sialadenitis is in most instan‐
ces either autoimmune or of unknown etiology with superimposed bacterial infections and
should not be designated as a chronic bacterial infection [94].
 
 
 
 
 
 
 
 
 
 
Figure 13. A. 55y old diabetic man presented with a 2-week swelling of the right parotid gland treated via antibiotics.
B. US examination revealed an abscess cavity in lower pole of the parotid gland. C. Abscess was drained from small
skin incision parallel to natural skin crease.
7.1.2.1. Clinical presentation and diagnosis
Chronic sialadenitis is characterized by recurrent moderate swelling of the affected gland al‐
ternating with asymptomatic remissions. During flare-up the duct orifice appears inflamed
with accompanying purulent discharge. Symptomatology tends to become progressively
more severe with increasing number of flare-ups. Eventually in some patients, the clinical
manifestations of a flare-up can mimic that seen in acute sialadenitis including abscess for‐
mation [95]. With recurrent infection the gland atrophies and is replaced by fibrotic tissue,
which makes it permanently palpable. Many patients with chronic parotitis seek medical at‐
tention because of a non-tender asymptomatic parotid lump or diffuse swelling. Chronic
sclerosing sialadenitis of submandibular gland, characterized by progressive periductal fib‐
rosis, dilated ducts with a dense lymphocyte infiltration with lymphoid follicle formation
and acinar atrophy, is known as Küttner’s tumor. It creates a diagnostic dilemma, because
clinically it resembles a submandibular gland tumor and it is the known fact that 80% of tu‐
mors presenting in this organ are malignant [96].Clinical diagnosis of chronic sialadenitis
needs validation by imaging. Common diagnostic methods are US and sialography. Sialog‐
raphy can evaluate the possible cause and the location of obstruction and enables assess‐
ment of progression; however, it is an invasive method and is currently being supplanted by
MRI sialography, which provides 3-dimensional images of the salivary gland without con‐
trast medium or exposure to ionizing radiation [97]. A new effective method for diagnosis
and also treatment of the obstructive disorders of SGs is sialoendoscopy [98,99].FNAC or in‐
cisional biopsy is advised for lesions that are still not diagnosed after complete clinical and
radiographic evaluation.
7.1.2.2. Treatment
An appropriate antibiotic should be used during an acute flare-up. Specific treatment is in‐
stituted for any structural abnormality, stricture or calculus. Oral and dental hygiene with
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mouthwashes, massage and compresses are useful. In the majority of cases of chronic paroti‐
tis, the disease will subside without an operation. More aggressive treatment is justified on‐
ly for those patients with persistent problems. Total parotidectomy is advised only with
frequent attacks and severe, progressive disability [100]. In a case of chronic submandibular
sialadenitis, when the function is destroyed, the treatment is by surgical excision. Interven‐
tional sialoendoscopy is an innovative approach to management of chronic sialadenitis. It
mainly includes sialolith or ductal polyp removal. When present, sialodochitis can be con‐
trolled by continuous lavage and drug perfusion in the duct. It has also been reported that
polyethylene stents can be used to prevent obstruction of the duct lumen by postoperative
edema, to allow particles of calculus to be washed out by the saliva and to reduce the possi‐
bility of stenosis. [99]
7.1.3. Juvenile recurrent parotitis
This separately recognized suppurative disease of the parotid glands is characterized by re‐
current unilateral or bilateral parotid swellings that may persist into adulthood. Age of on‐
set is most commonly between 3 and 6 years, while complete remission is usual at the time
of puberty. An early age at the first episode is associated with an increased risk of recurrenc‐
es. The episodes of parotid swelling may occur several times per year and overall number of
recurrences can reach several dozen. [101,102] The etiology and pathogenesis of this condi‐
tion are largely unknown. Numerous factors were suggested as causative: congenital mal‐
formation of the ductal system, hereditary and genetic factors, allergy, autoimmune disease,
IgA or IgG3 deficiency [102,103].
7.1.3.1. Clinical presentation and diagnosis
Findings include recurrent episodes of glandular swelling which typically last for several
days up to 2 weeks, and which may occur more than 10 times per year, generalized malaise
and pain. On clinical examination the affected gland is swollen and tender, mostly without
overlying skin changes. Saliva expressed from the duct is thick and contains floccules of in‐
spissated mucus or pus. US is the appropriate initial imaging investigation, and is usually
supplemented by sialography after acute symptoms have subsided. (Figure 14)
 
 
 
 
 
 
 
 
 
 
Figure 14. A. 15y old boy with history of recurrent right parotid swelling since the age of 6. B. Orrifice of Stensen’s
duct is slightly erythematous and expressed saliva contains whitish floccues. C. US examination showed numerous hy‐
poechogenic loci consistent with sialectasis.
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7.1.3.2. Treatment
Acute episodes are managed conservatively with hydration, stimulation of salivation, fo‐
mentations and analgesic-antipyretic medication. Patients with fever and frank purulent
exudation may require a course of antibiotics. The sialography with iodinated oil may itself
cause an improvement of the condition [104].
7.2. Viral infections
Viral infection of the SGs most commonly occurs through hematogenous dissemination, al‐
though infection by retrograde ductal migration does occur. Viral infestation of salivary pa‐
renchyma can be accompanied with local and/or systemic manifestations. There is a wide
range of viral infections that can involve SGs, which include Coxsackie virus A and B3, Para‐
influenza virus B, Influenza virus, ECHO virus type 9, Epstein-Barr virus, HIV, enteroviruses,
Cytomegalovirus and Lymphocytic choriomeningitis virus. [89,92]
7.2.1. Mumps
Mumps is the most common childhood viral disease, causing nonsuppurative acute siala‐
denitis. Adults are rarely infected due to life-long immunity incurred by childhood expo‐
sure  or  MMR vaccination.  Mumps virus,  the  causative  agent  of  mumps infection,  is  an
enveloped RNA virus  that  belongs  to  the  genus Rubulavirus  in  the  family  Paramyxoviri‐
dae. The virus is endemic in the community and spreads efficiently by air-borne droplets
from salivary,  nasal  and urinary  excretions.  The  incubation  period  is  between  15  to  24
days  and  averages  18-19  days.  Infective  virus  is  shed  through  the  saliva  for  up  to  a
week following gland enlargement. [89]
7.2.1.1. Clinical presentation and diagnosis
Mumps is characterized by pain and swelling of one or both parotid glands, accompanied
by low-grade fever, arthralgia, malaise, and headache. Bilateral parotid gland swelling oc‐
curs in most cases, but submandibular gland swelling can also occur in rare cases. Progres‐
sion of parotid gland swelling can be rapid and sufficient to cause displacement of the
pinna. Pain is usually exacerbated by the physiologic stimulus of eating, which causes con‐
tractile ejection of saliva from the inflamed gland. Findings at the orifice of the parotid duct
are usually absent but sometimes the orifice can become edematous and erythematous. Duc‐
tal epithelial desquamation may lead to secondary ductal obstruction and dilatation. While
the parotids are the most commonly affected organs, parotitis is not a primary or necessary
step for mumps infection. More fulminant infections occasionally progress to include me‐
ningoencephalitis, orchitis, pancreatitis, and nephritis. Routinely obtained laboratory tests
are usually unremarkable except for occasional leukopenia. Elevations in serum salivary
type iso-amylase parallels the pattern and duration of glandular swelling. Laboratory inves‐
tigation is rarely required given the characteristic features present in all but exceptional cas‐
es. A laboratory diagnosis is based on isolation of the mumps virus, detection of viral
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nucleic acid, or serological confirmation. Histological examination reveals substantial cyto‐
plasmic vacuolization of acinar cells. [89,92,105]
7.2.1.2. Treatment
As with any viral illness, there is no specific antiviral therapy for mumps and treatment
is  mostly  symptomatic  and  supportive:  supplemental  hydration  and  rest,  with  dietary
modifications to minimize glandular secretory activity.  Generally,  the symptoms of vire‐
mia,  including  fever,  arthralgia,  malaise,  and  headache,  begin  to  abate  within  3  to  7
days.  The  resolution  of  gland  swelling  usually  requires  several  weeks,  frequently  pro‐
ceeding asymmetrically. [92]
7.3. Fungal infections
Fungal infection is an unusual cause of SG pathology, however there are several reports
in  the  literature  about  infection  of  salivary  gland  with  Candida  albicans  [106],  Candida
glabrata  [107]  Apophysomyces  elegans  [108]  and Rhizopus  spp.  [109].  Fungal  salivary infec‐
tion usually occurs in debilitated hosts and this is maybe due to the toxicity of saliva to
fungi under normal conditions. The definite diagnosis is made by culturing the purulent
discharge  from  duct  or  by  culture  of  the  pus  obtained  at  surgical  drainage  of  the  ab‐
scess, but most readily by tissue biopsy. The treatment will involve an appropriate anti‐
fungal  medication  depending  on  the  laboratory  analysis,  incision  and  drainage  of  any
formed abscess and total or partial excision of the gland because some infections are in‐
vasive and life threatening.
7.4. Parasite infections
Apart  from involvement  of  the  parotid  gland  by  toxoplasmosis  [110],  we  were  able  to
find only one case of parasitic SG infestation in the English literature. A nematode larva,
morphologically  consistent  with Strongyloides  stercoralis  was  found in  the  cytological  ex‐
amination  of  a  41-year-old  man who underwent  incision  and drainage  of  a  right-sided
parotid  swelling  because  of  poor  response  to  the  aspiration and drainage  with  intrave‐
nous antibiotic therapy. The abscesses regressed significantly after administration of Iver‐
mectin. [111]
7.5. Granulomatous infections
Granulomatous SG infections not infrequently represent a manifestation of a chronic granu‐
lomatous disease involving the lymphatic network in and around the parotid gland. Also
direct infiltration of the adjacent glandular parenchyma occurs in fulminant cases. Manifes‐
tations frequently feature asymptomatic gradual enlargement of a nodule within the gland
substance, suggesting a neoplasm. Included among these diseases are mycobacterial diseas‐
es (tuberculous and atypical forms), actinomycosis, cat scratch disease, and tularemia. [92]
For details see respective sections of this chapter.
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8. Paranasal sinuses infections
Sinusitis is one of the most common condtions in primary care. Because infection causes in‐
flammation of both the sinuses and the nasal cavity, the term "rhinosinusitis" instead of the
more common sinusitis has been recently coined [112,113]. The precipitating factor in acute
sinusitis seems to be blockage of the sinus ostium, typically the maxillary sinus ostium situ‐
ated under the middle turbinate, with mucus retention and subsequent infection. Viral infec‐
tion of upper respiratory tract triggers most cases. Only 0.2-2% of cases become complicated
by bacterial infection [113]. Worsening symptoms after 5 days or persistent symptoms be‐
yond 10 days (but less than 12 weeks) indicate non-viral rhinosinusitis; whereas viral dis‐
ease lasts less than 10 days [112]. A small proportion of cases of bacterial sinusitis can arise
as a result of periapical infection or untreated post-extraction oro-antral communication.
Odontogenic maxillary sinusitis comprises 10–12% of bacterial sinusitis; however, recent
studies suggest that this figure is much more frequent and closer to 30%. [114]
8.1. Clinical presentation and diagnosis
Acute rhinosinusitis, according to The European Academy of Allergology and Clinical Immu‐
nology, is characterized by two or more of the following symptoms: nasal congestion with
blockage, discharge (anterior or postnasal drip), facial pain and/or pressure and reduction or
loss of smell, lasting less than 12 weeks. Additional symptoms, not invariably present, are
toothache of upper teeth, pain on stooping, and fever or malaise. [115]
 
 
 
 
 
 
 
 
 
 
Figure 15. A. 16y old male hospitalized in ENT department was referred to rule out odontogenic source of his right
sided pansinusitis. B. Notice distended edematous soft tissues of forehead. C. Complete opacification of all right sided
paranasal sinuses. Patient was treated by endoscopic sinus surgery and intravenous antibiotics.
Chronic rhinosinusitis is characterized by nasal congestion or blockage lasting more than 12
weeks and accompanied by at least one of the following symptoms: facial pain or pressure,
discolored nasal discharge or postnasal drip and reduction or loss of smell. Most instances
of sinusitis are diagnosed clinically. In the workup of suspected acute rhinosinusitis, plain
radiography is neither useful nor warranted [115]. X-ray examination of the sinuses, CT, ul‐
trasonography, sinus puncture, and culture of aspirate can be helpful in complicated and
chronic cases [112]. Dental symptoms, such as pain and dental hypersensitivity, do not relia‐
bly predict an odontogenic cause. The most usual characteristic of an odontogenic sinusitis
is the presence of unilateral symptoms [114].The complications of sinusitis are due largely to
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the proximity of the paranasal sinuses to the anterior cranial fossa and orbit, as well as the
venous drainage of the mid-facial structures into the intracranial venous sinuses. Up to 75%
of orbital infections are attributable to sino-nasal disease, namely ethmoiditis. Frontal sinusi‐
tis may lead to osteomyelitis of the frontal bone (Pott’s puffy tumor) [116]. Other life- threat‐
ening complications include extradural and subdural empyema, meningitis, intracranial
abscess, and cavernous sinus thrombosis. (Figure 15)
8.2. Treatment
Acute rhinosinusitis is managed symptomatically with analgesics and topical steroid spray.
Symptom relief can also be achieved with the use of topical saline douches and sprays. Anti‐
biotics are recommended if symptoms are severe, persistent (>5 days), or progressive.
[112,118] The gold standard for establishing bacterial etiology of acute rhinosinusitis is a
maxillary sinus tap. However, it is not a routine procedure and is usually reserved for re‐
search purposes or for patients not responding to initial medical therapy. A suitable alterna‐
tive may be nasopharyngeal culture. [118] Even in the absence of detectable sinus bacterial
infection, the presence of nasopharyngeal bacterial colonization can result in the develop‐
ment of secondary bacterial sinusitis. Inflammation of the mucosal lining of the paranasal
sinus causes a functional obstruction of the osteomeatal complex. It is thought that oxygen
within the sinus is depleted as molecular oxygen is absorbed, resulting in negative pressure
promoting the aspiration of bacteria from the nasopharynx. Another mechanism of paranas‐
al sinus inoculation with bacteria is nose blowing. [118] Once a bacterial cause is established
based on clinical presentation, empiric antimicrobial therapy should be initiated, depending
on the resistance patterns of the usual pathogens: S. pneumoniae, H. influenzae and M. catar‐
rhalis. Antibiotics that cover β-lactamase producing bacteria, like amoxicillin–clavulanate,
are reasonable choices. Other options include cephalosporins or macrolides. [112] If an anti‐
biotic is effective, clinical improvement should be seen within 2–3 days [118].
Clinical studies have recently confirmed that about 60% of presumed bacterial sinusitis re‐
solves spontaneously without antibiotics. For instance, in a double-blind, randomized, pla‐
cebo-controlled factorial trial of 240 adults (aged ≥16 years) with acute non-recurrent
bacterial sinusitis, neither an antibiotic nor a topical steroid alone or in combination were
effective in altering the symptom severity, the duration, or the natural course of the condi‐
tion [119]. Despite this evidence, antibiotics are still overused, which ads to treatment costs,
puts patients at risk of adverse events and ads to growing antimicrobial resistance
[113].Treatment of chronic rhinosinusitis should begin with topical nasal steroids along with
aggressive treatment of any underlying cause or comorbid allergy. Oral steroids should be
reserved for refractory cases. Caution should be taken in at-risk groups, including patients
with diabetes or active peptic ulceration. Antibiotics may be indicated in patients who have
failed to respond to initial intranasal steroid therapy or in those who have severe symptoms
with evidence of persistent nasal bacterial infection. [112,113] Surgery for rhinosinusitis
should be considered only after conservative treatment has failed or complications develop.
In acute rhinosinusitis sinus lavage performed endoscopically or via external trephination of
canine fossa can drain pus and decompress the affected sinus. Traditional open sinus proce‐
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dures for chronic rhinosinusitis, like Caldwell-Luc operation, have been supplanted by en‐
doscopic techniques. With a better understanding of normal mucociliary clearance
pathways and anatomy of the osteomeatal complex, functional endoscopic sinus surgery is
now the mainstay of surgical treatment. [112] Patients with recurrent acute sinusitis or
chronic sinusitis should be evaluated for underlying allergy. As many as 60% of patients
with chronic sinusitis have allergic sensitivities to perennial allergens like house dust mites,
cockroaches, pet dander and fungi. These allergies should be identified and treated before
the patients are considered for sinus surgery [113].Although symptoms and exam findings
in odontogenic and nonodontogenic sinusitis are similar, odontogenic sinusitis differs in the
pathogenesis, spectrum of microbiology findings and treatment strategies and its therapy is
therefore not discussed in this chapter.
9. Orbital infections
Infections of the orbit make up less than 1% of all orofacial acute bacterial inflammations.
Their rarity may lead to late diagnosis and consequential serious complications: impairment
of visual acuity, blindness, or in extreme cases even death due to intracranial spread
[120].The orbit is surrounded by frontal bone, major and minor wing of sphenoid bone, orbi‐
tal facet of vertical plate of palatinal bone, lamina papyracea of ethmoid bone, lacrimal bone,
maxilla and zygomatic bone. Several of these bones contain pneumatized paranasal sinuses.
The ethmoidal sinus and maxillary sinus are separated from the orbital cavity by very thin
bone shell. There are also numerous bony foramina and fissures containing neurovascular
bundles, along which the infection processes can spread into orbit and intracranially: optical
foramen, superior and inferior orbital fissure, anterior and posterior ethmoidal foramen, in‐
fraorbital canal and foramen, nasolacrimal canal, supraorbital and supratrochlear foramen.
Another route of orbital involvement by adjacent infectious process is thromboflebitis of or‐
bital veins, which are connected to facial venous system by angular, infraorbital, supraorbi‐
tal, supratrochlear and pterygoid plexus veins. The ophthalmic veins communicate also
with the veins of the sinuses, especially the ethmoid sinus. The ophthalmic veins drain into
the cavernous sinus, and therefore infections can spread intracranially. Veins in this region
are valveless and can have retrograde flow. This makes venous orbital system prone to con‐
gestion. [121] Orbital infections are usually classified as pre-septal or post-septal according
to their relationship to orbital septum, connective tissue membrane, which arises from the
orbital margin and radiates into upper and lower tarsus of the eyelids. [121]. Conditions re‐
garded as preseptal orbitocellulitis are quite frequent. They accompany many orofacial and
upper respiratory infection processes, especially odontogenic infections originating in the
maxilla. Children are regularly affected by this scary-looking condition; however, it recedes
readily after the underlying cause has been eliminated. In these cases periorbital soft tissues
and eyelids are affected by edema, but ocular findings like globe position, motility and vi‐
sion remain normal. Only post-septal processes can therefore be considered true orbital in‐
fections. (Figure 16)
A Textbook of Advanced Oral and Maxillofacial Surgery100
Figure 16. old girl hospitalized in the ophthalmology ward was referred to rule out odontogenic source of preseptal
orbitocellulitis. Note crusted nasal secretion suggesting acute rhinosinusitis.
In postseptal orbital cellulitis there is diffuse edema of the orbital contents and actual infil‐
tration of the adipose tissue with inflammatory cells and bacteria, but no discrete formation
of abscess. In subperiosteal orbital abscess, there is a collection of pus between the perios‐
teum and the bony wall of the orbit, while in intraorbital abscess pus collection is present
within the orbital tissues. [122,123] (Figure 17)
Figure 17. Clinical presentation of acute postseptal orbitocellulitis with chemosis, proptosis and ophthalmoplegia.
Courtesy of Dr. Sabreyah Al-Saleh, Ophthalmology Department, Al-Adan Hospital.
The close relationship between the orbit and paranasal sinuses is responsible for the majori‐
ty of orbital infections, especially in children. Paranasal sinusitis, mostly ethmoiditis fol‐
lowed by maxillary sinusitis, precedes 60 – 84% of orbital infections. [124,125] Other sources
of orbital infections are trauma, retained foreign bodies, periorbital suppurative skin diseas‐
es, hordeolum or chalazion, dacryocystitis and conjunctivitis. Odontogenic infection of the
orbit is rare. The pathway can be via the maxillary sinus, the canine fossa with a thrombo‐
phlebitis of the angular vein, or the pterygopalatine fossa and infratemporal fossa and fur‐
ther through the inferior orbital fissure. [120] The causative microorganisms in acute orbital
infections are usually those associated also with paranasal sinusitis. Before introduction of
vaccination, H. influenzae was the most common pathogen responsible for orbital cellulitis.
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Currently, the most common bacterial isolates include the Staphylococcus species, Pseudomo‐
nas species, Streptococcus species, Moraxella catarrhalis, and Eikinella corrodens as well as anae‐
robic organisms like Peptostreptococcus, Fusobacterium, and microaerophilic Streptococcus.
[121] In young children aerobes prevail, while in older patients anaerobes can also be found.
Polymicrobial infections are more frequent in adult patients. [122]
9.1. Clinical presentation and diagnosis
Symptoms depend on the stage of the infectious process, which begins with postseptal orbi‐
tal cellulitis accompanied by swelling and erythema of eyelids, conjunctival chemosis, limit‐
ed ocular motility, visual disturbances and proptosis due to developing intraconal edema.
Development of subperiosteal abscess can lead to displacement of the bulbus with resulting
diplopia. Intraconal progress of infection is marked by increasing exophthalmia, abnormal
pupillary reflexes, ophthalmoplegia, impaired color vision and decreasing visual acuity.
Eyeball is painful to touch and patient suffers from severe headache. The disease is accom‐
panied by septic fever and laboratory signs of acute bacterial infection. Untreated or inade‐
quately treated disease finally progresses into thrombophlebitis of cavernous sinus with
complete paralysis of related cranial nerves, loss of vision, altered mental status and gener‐
alized sepsis. Mortality rate of cavernous sinus thrombophlebitis remains high. There is usu‐
ally very little to be gained by conventional radiology examination. Plain radiographs are
reserved for very young children in whom the risk of sedation for the CT scan and radiation
burden outweigh the possible diagnostic yield [121]. CT scan or MRI imaging should be per‐
formed without delay to serve as an indicator and guide for surgical intervention. I it will
help to elucidate the status of the paranasal sinuses, where majority of infections originate.
Although CT still remains the modality of choice for the diagnostic workup of orbital infec‐
tion, MRI should be considered particularly in the pediatric population [126]. Recently, there
was some progress in employment of US as a readily available, inexpensive imaging meth‐
od for diagnosing and monitoring orbital infections, especially in children, where radiation
dose is a major concern [127].
9.2. Treatment
Patients with cellulitis, without evidence of a subperiosteal or intraorbital abscess, can usu‐
ally be treated with parenteral antibiotics alone. The antibiotic should be broad spectrum
and to cover aerobes as well as anaerobes. Second- or third-generation cephalosporins, am‐
picillin-sulbactam, ticarcillin-clavulanate, clindamycin, aminoglycosides, fluoroquinolones
or carbapenems are among those recommended. [121,128] Surgical incision and drainage of
the subperiosteal or intraorbital abscess is the mainstay of therapy and should be considered
an emergency procedure. Primary source of infection should be addressed at the same time.
The optimal way of draining orbital abscess is endoscopic access via paranasal sinuses,
namely in cases originating in sinusitis [128]. Otherwise, surgical access to the orbit is
through periorbital skin incisions like Lynch, infraorbital or lateral eyebrow. Cosmetic ap‐
proaches used in orbital traumatology are not indicated here, because they do not allow
placement of proper drains and/or they would bring purulent exudate into the conjunctival
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sac and contaminate the cornea. Surgical intervention should be complemented by aggres‐
sive intravenous antibiotic therapy without waiting for results of microbiology examination
and sensitivity testing. Benefits of corticosteroid therapy aimed at reducing orbital edema is
questionable. It should be administered only if mycotic etiology has been ruled out.
10. Interstitial fungal infections
There are about 100,000 different species of fungi worldwide, but only a few are pathogenic
for humans, and most of them show distinct geographic distribution. With the exception of
candidiasis, other fungal infections are extremely rare and consequently medical and dental
practitioners have limited experience and knowledge in their diagnosis and management.
Accurate and early diagnosis, which often is not easy, should lead to prompt and aggressive
therapy to prevent spread, dissemination and death. Fungal infections rarely afflict healthy
immunocompetent individuals. However, recent years saw a dramatic increase in the num‐
bers of immunocompromised patients, above all HIV infected persons, diabetics, patients
with hematologic malignancies, transplant recipients and other patients receiving immuno‐
suppressive drugs. Clinicians should be aware of these rare mycoses and include them in
the differential diagnosis when dealing with unusual or unexplained symptoms. The labora‐
tory methods available to diagnose fungal infections include biopsy and culture of tissue,
body fluids, secretions, tests for antigens and serum antibodies. Biopsy investigation is the
key to correct diagnosis and should include special stains such as periodic acid-Schiff and
Grocott-Gomori methenamine silver nitrate. For yeasts, culture is necessary to identify the
etiologic agents. Filamentous fungi, in particular zygomycetes and dimorphic fungi can be
diagnosed by histological examination and pertinent stains with or without isolation of the
fungus from the same site. [129]
10.1. Candidiasis
Candida, the most common cause of opportunistic infection worldwide, is thin-walled, small
yeast (4-6 μ) that reproduce by budding. The genus Candida includes approximately 154 spe‐
cies, but only 6 are frequently isolated in human infection. Candida albicans is the most abun‐
dant and significant species. Other causative agents include C. tropicalis, C. glabrata, C.
parapsilosis, C. krusei, and C. lusitaniae. Invasive Candida disease is composed of a variety of
entities, including candidemia, disseminated candidiasis, endocarditis, meningitis, and en‐
dophthalmitis. [130] In orofacial areas the most frequent form of Candida infection is stomati‐
tis. It takes on several well known clinical manifestations, like angular cheilitis, denture
stomatitis and rhomboid median glossitis. These superficial mucosal diseases are usually
due to local compromising factors and can be found in otherwise healthy individuals. Topi‐
cal antifungal treatment with correction of underlying problem is usually sufficient for cure.
Disorders of cell-mediated immunity are associated with severe or recurrent pseudomem‐
branous candidiasis, whereas neutropenia or impaired neutrophil functions are associated
with invasive infections. [131] (Figure 18)
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Figure 18. A. 40y old diabetic woman was referred by a dentist for evaluation of non-healing wound after extraction
of tooth 26 done 6 months earlier. B. CT examination revealed partial opacification of the maxillary sinus and signs of
osteomyelitis. The patient underwent surgical debridement. Histopathology examination revealed massive Candida
infiltration.
10.2. Cryptococcosis
The Cryptococcus genus includes spherical opportunist yeasts that generally lack a mycelium
but have a polysaccharide capsule. Two Cryptococcus species can cause diseases in humans.
Cryptococcus neoformans is ubiquitously distributed. It has been isolated in the soil and in the
feces of birds, such as pigeons, canaries, and parrots. Cryptococcus gattii has the koala bear as
a natural reservoir, and it is endemic in Australia, where it is also frequently found on euca‐
lyptus trees. Cryptococcus neoformans infection generally affects immunocompromised hosts,
whereas C. gattii is more often isolated in immunocompetent subjects. [129] Cryptococcosis
is one of the most common life-threatening systemic fungal infections in HIV infected pa‐
tients with mortality rate of 30-40%. The onset of the infection follows inhalation of the
spores, with primary localization in lungs from which they spread through the bloodstream
to the central nervous system, causing meningitis. There have been only sporadic reports of
orofacial manifestations. The affected locations included oral mucosa, parotid gland, para‐
nasal sinuses and temporal area with associated osteomyelitis. [132-6]
Combination of amphotericin-B and flucytosine is the treatment of choice for the first 2
weeks, followed by fluconazole maintenance therapy.
10.3. Aspergillosis
Aspergillosis is an infection caused by a fungus of the Aspergillus family. Aspergillus species
are commonly found in the soil and decaying vegetation. Infections due to Aspergillus spe‐
cies are caused in most cases by Aspergillus fumigatus, far ahead of Aspergillus flavus, Asper‐
gillus niger, Aspergillus terreus and other Aspergillus species. [137] The manifestation and
severity of the aspergillosis depends upon the immune status of the patient. Although As‐
pergillus conidia inhalation is very common, the disease is rare in healthy subjects. Patients
at highest risk are those with hematological malignancies and severe neutropenia, AIDS,
chronic obstructive pulmonary disease, solid organ transplant recipients, and patients in the
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intensive care unit receiving steroids. Invasive Aspergillus infections most commonly affect
the lung and paranasal sinuses. Other forms of the disease are central nervous aspergillosis,
osteomyelitis, endophthalmitis, endocarditis, and disseminated form of aspergillosis.
[129,137] The maxillary sinus is the most common orofacial site of invasive aspergillosis. The
disease is characterized by spread of the fungus from the sinus into adjacent structures. If
not aggressively treated, it can invade the brain, causing a high mortality rate. Commonly
reported symptoms of invasive sinus aspergillosis are nasal congestion, nasal discharge, ab‐
normal findings in the nasal cavity, buccal swelling with pain, and hypoesthesia. Primary
oral invasive aspergillosis is rare. The most frequently affected site is the gingiva, followed
by the hard palate. The necrotic mucosal ulceration can progress to affect underlying bone.
[138] A case of mandibular involvement has also been reported after tooth extraction in a
diabetic patient. [129]Successful treatment of invasive aspergillosis requires prompt diagno‐
sis and rapid institution of aggressive therapy. Any delay or nonaggressive therapy can re‐
sult in the spread of infection with lethal consequences. Treatment of choice is surgical
debridement with antifungal therapy using amphotericin B, itraconazole, voriconazole, and
echinocandins. [137,138] The most frequent form of aspergillosis encountered in maxillofa‐
cial area of immunocompetent patients is Aspergillus mycetoma (AM) of the maxillary sinus.
Also known as aspergilloma or fungus ball, it is a noninvasive extramucosal mycotic infec‐
tion. Predisposing factors include poorly ventilated sinus, a pre-existing chronic sinusitis, or
foreign bodies in the sinus. Overfilling of endodontic sealers into the sinus may be a cause.
Zinc oxide contained in sealers paralyzes the epithelial cilia and causes edema and hypere‐
mia of the soft tissues that may promote Aspergillus growth. Symptomatic patients usually
present with signs of chronic sinusitis with nasal secretions, pain, and sometimes facial ede‐
ma. The disease can be also asymptomatic and is revealed during routine radiographic ex‐
amination. The treatment of AM is surgical. Traditional Caldwell-Luc procedure, which has
been used until recently, has detrimental consequences for sinus physiology. It was sup‐
planted by endoscopic sinus surgery with middle meatal antrostomy. Combined approach
with intraoral surgical access remains reserved for selected cases in which endoscopic sur‐
gery does not permit complete removal of fungus material and foreign bodies. General or
local antifungal drugs are not indicated. [139]
10.4. Zygomycosis
Zygomycosis is fungal infection also known under designations phycomycosis or mucor‐
mycosis.  The  term phycomycosis  is  obsolete  and refers  to  some of  organisms currently
classified as  Zygomycota.  The term mucormycosis  refers  to  fungi  in  the order  Mucorales.
While the term zygomycosis includes also Entomophthorales,  the order of Zygomycetes,  as
possible etiological agents, the term mucormycosis excludes this group and concerns on‐
ly organisms belonging to the order of Mucorales. The order of Entomophthorales is of lim‐
ited  concern  because  it  does  not  possess  the  same degree  of  invasiveness  as  Mucorales.
Two genera of Entomophthorales are known to be implicated in human disease: Conidiobo‐
lus  and Basidiobolus,  responsible for subcutaneous infections and, less frequently, for dis‐
seminated forms. [140]
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The phylum Zygomycota comprises about 600 species, principally occurring in soil enriched
with decaying organic matter. The usual human pathogens belong to genera Absidia, Mucor,
Rhizomucor and Rhizopus. The predominant human pathogen is Rhizopus (oryzae) arrhizus, ac‐
counting for 60% of all forms of zygomycosis and 90% of rhino-orbito-cerebral zygomycosis
cases. [141]The mechanism of inoculation is most often by inhalation of spores and therefore
respiratory tract or lungs are affected. Up to one half of all zygomycosis cases originate in
paranasal sinuses. Another important infection route is percutaneous inoculation. This in‐
cludes traumatic and surgical wounds, medicine or illicit drug injections, tattoo, insect bites
or stings. Deglutition of contaminated food, drinks, herbal or homeopathic remedies can
lead to infections of digestive tract. Other organs can be affected either by direct or hemato‐
genic spread due to angioinvasive nature of the fungus.The infection typically occurs in im‐
muno-compromised patients. The main target group consists of poorly controlled diabetes
mellitus patients. Diabetic ketoacidosis leads to dysfunction of monocytes/macrophages and
impairment of action of neutrophiles. Another target group is patients with solid tumors,
leukemias and lymphomas with chemotherapy-induced neutropenia being the principal
risk factor. Other risk factors are systemic steroids, myelosuppresive therapy in bone mar‐
row and solid organ transplant recipients, iron overload and its deferoxamin treatment in
patients on dialysis. Wide-spectrum antibiotics can promote zygomycosis by eliminating
bacterial competition. [141-3] Cases of zygomycosis have also been reported among healthy
individuals with no known risk factor. [144] Many of these cases have been ascribed to Apo‐
physomyces elegans, relatively recently discovered Zygomycete. [145] The majority of cases in
previously healthy patients follow invasive procedures or trauma with extensive damage of
soft tissues. Local ischemia and resulting acidosis can provide favorable conditions for pro‐
liferation of an infection.
10.4.1. Clinical presentation and diagnosis
Majority of orofacial zygomycosis cases originate in paranasal sinuses, especially in diabetic
patients. Initial signs include nasal obstruction, mucopurulent or bloody nasal discharge, na‐
sal crusting, facial pain, headache, facial swelling, and cellulitis. In acutely progressing cas‐
es, orbital involvement is a common clinical feature, even on presentation. (Figure 19)
Zygomycosis should be considered in all patients with orbital inflammation associated with
multiple cranial nerve palsies and retinal or orbital infarction, regardless of their immuno‐
logic status. Initial orbital involvement is an alarming sign, because it can lead to intracrani‐
al progression with grave prognosis. CT scan at this initial stage often reveals only minimal
mucosal thickening of the sinuses. Blood tests, cerebrospinal fluid examinations, and cul‐
tures from paranasal sinuses fluid are of no diagnostic help; only the detection of typical
fungal hyphae in the infected tissue is diagnostic. The early collection of biopsy sample is
therefore of utmost importance. [146-8] Chronically developing zygomycosis of paranasal si‐
nuses results in extensive necrosis and destruction of mid-facial bony architecture and can
manifest itself by hard palate ulceration over necrotic bone and finally palate perforation.
(Figure 20)
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Figure 19. A. Ten day orbital cellulitis in a previously healthy young man, unsuccessfully treated by antibiotics and cor‐
ticosteroids.B. MRI scan revealed proptosis with stretching of the optical nerve, deformation of the bulbus, thickening
of ocular muscles, inflammatory changes of orbital fat, homolateral ethmoid cells and temporal fossa. C. Exploratory
orbitotomy encountered bulging avascular periorbita. D. Groccot-Gomori stain of biopsy specimen depicted hyphae
of zygomycete, which was classified by subsequent culture as Apophysomyces elegans. Despite orbital exenteration
and Amphotericin B therapy the patient died 5 days later due to intracranial invasion. [145]
 
 
 
 
 
 
 
Figure 20. A. Female patient treated by chemotherapy for acute myeloid leukemia was referred for evaluation of ex‐
tensive palatal necrotic ulcer. B. CT scan revealed nearly complete opacification of maxillary sinus. Patient underwent
partial maxillectomy and was diagnosed with zygomycosis. She died later due to complications of chemotherapy.
10.4.2. Treatment
Effective therapy requires prompt surgical intervention, systemic antifungal drug adminis‐
tration and reversal of the underlying immunocompromising condition. The only agent ac‐
tive against most Zygomycetes species has been until recently amphotericin B. It is the drug
of choice for treatment of zygomycosis and it is recommended that therapy should be start‐
ed as soon as the diagnosis is confirmed. The use of amphotericin B is limited by frequent
side effects, most importantly the dose-limiting nephrotoxicity. Most of the negative side ef‐
fects can be avoided by using preparations of amphotericin B combined with lipid struc‐
tures. Also introduction of new azoles such as posaconazole and voriconazole may provide
hope for better therapeutic outcomes. [149,150] Zygomycetes invading host tissues have a
tendency to grow inside vascular channels, which leads to thrombosis and subsequent is‐
chemic tissue necrosis. Intracavitary/interstitial and cerebrospinal fluid perfusion pathways
may ensure availability of antibiotic in tissues affected by intra-arterial invasion by mycelia
and thrombosis. [151] The overall mortality rate of zygomycosis is approximately 44% but
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for patients with rhinocerebral form it reaches 85% and remains more or less unchanged de‐
spite progress in antifungal pharmacotherapy. [152]
10.5. Histoplasmosis
Histoplasmosis is a mycosis caused by Histoplasma capsulatum, a saprophytic dimorphic fun‐
gus found globally in soil. Dimorphic fungi are microorganisms that can grow either in my‐
celial form in the external environment or in yeast-like form in the host tissues. The
morphologic transformation from mold to yeast confers virulence to these microorganisms,
so that they are able to cause disease even in immunocompetent hosts. [129] Endemic loca‐
tions of histoplasmosis include the Ohio and Mississippi River valley, scattered areas of
Central and South America, Africa, Asia, the Far East, and Australia. [153] Human contami‐
nation occurs by inhalation of the airborne spores, which are phagocyted by pulmonary
macrophages and reside within a membrane-bound vacuole. Immunocompetent persons ex‐
posed to a low inoculum develop antigen-specific CD41 T-lymphocyte mediated cellular im‐
mune responses with activation of macrophages and the disease is controlled. [154] In
immunocompromised host, mainly HIV-positive patients, H. capsulatum can spread through
the reticuloendothelial system and lead to potentially lethal generalized disease. Upper aer‐
odigestive involvement has been reported in patients with chronic pulmonary and chronic
disseminated forms of histoplasmosis and may be the initial or only manifestation of the dis‐
ease. [155] It may also be the first manifestation of AIDS. Lesions frequently present as pain‐
ful ulcers covered by pseudomembrane, nodules, or vegetations. Oral lesions associated
with H. capsulatum may occur in isolation or associated with pharyngeal and laryngeal le‐
sions and are present in 30% to 50% of patients with disseminated histoplasmosis. They may
mimic other ulcerated lesions, such as squamous cell carcinoma, tuberculosis, and other
deep mycoses. [156-8] Specific complication of pulmonary histoplasmosis is the develop‐
ment of a mediastinal granuloma, characterized by a mediastinal mass (3-10 cm) comprised
mostly of caseous mediastinal lymph nodes that have matted together and broken down in‐
to a single semiliquid encapsulated lesion. Histoplasmosis infection in the neck is a rare pre‐
sentation and is probably due to the spread of histoplasmosis from the mediastinum to
cervical lymph nodes. Neck masses have histopathology characteristics similar to histoplas‐
mosis mediastinal granulomas. [159] Surgical treatment of histoplasmosis orofacial lesions
by itself is not effective and must be complemented by antifungal therapy. Typical manage‐
ment of severe disease first involves treatment with amphotericin B, followed by oral itraco‐
nazole. Treatment with itraconazole will need to continue for at least 1 year. In milder cases,
oral itraconazole or ketoconazole is sufficient. [156]
11. Deep neck infections
Infections of deep fascial compartments of the head and neck can be challenging in diagno‐
sis and management. Because of the anatomic communication between fascial neck spaces,
the infection processes easily spread beyond the original site and can lead to life threatening
complications. Most deep neck abscesses are polymicrobial; the average number of isolates
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is five (range 1–10). Anaerobic bacteria can be isolated from most abscesses when appropri‐
ate culture techniques are employed. Predominant anaerobic organisms isolated in periton‐
sillar, lateral pharyngeal and retropharyngeal abscesses are Prevotella, Porphyromonas,
Fusobacterium and Peptostreptococcus spp. Aerobic organisms are group A β-hemolytic strep‐
tococci, S. aureus and H. influenzae. [90,160]
11.1. Peritonsillar abscess
The most common deep neck infection is peritonsillar abscess. Peritonsillar abscesses mostly
occur as a complication of repeated episodes of bacterial tonsillitis, but they can occasionally
occur as a complication of a viral infection, such as Epstein–Barr virus mononucleosis. The
infection penetrates into the potential space between the superior constrictor pharyngis
muscle and the tonsillar capsule. [90,161]
11.1.1. Clinical presentation and diagnosis
The peritonsillar abscess is usually preceded by acute pharyngotonsillitis. The initial focus
of infection may have been resolved by the time of presentation. [161] Affected tonsil is
swollen and inflamed, but the soft palate does not bulge. The uvula is edematous and push‐
ed towards the opposite side of the infection. Patients have difficulty in swallowing or
speaking. They may be drooling because of pain on swallowing. Pain gradually increases in
severity, radiates to the ear and causes trismus as a result of spasm of the medial pterygoid
muscle. The breath has a foul odor. Ipsilateral cervical lymph nodes are enlarged and ten‐
der. CT examination, or intra-oral US, is helpful in distinguishing between abscess and cel‐
lulitis. [90]
11.1.2. Treatment
The therapy of choice is needle aspiration or incision and drainage of the abscess under local
or general anesthesia, supported by administration of parenteral antibiotics. Hospitalization
and general anesthesia are required in younger children. It is important to obtain adequate
specimens for microbial culture from the abscess as a variety of organisms can be recovered.
Specimens are best collected at the time of surgical drainage by needle aspiration. [160] Pa‐
tients with a peritonsillar abscess and a history of recurrent tonsillitis should be considered
for tonsillectomy after the acute episode has subsided. It is also possible to drain abscesses
by tonsillectomy during the acute stage of the disease.
11.2. Parapharyngeal abscess
The parapharyngeal space is a crevice extending from the level of hyoid bone to the base of
the skull. Its lateral border is made up by the medial pterygoid muscle and part of ascending
ramus of the mandible, the deep lobe of parotid gland with its investing fascia and inner
surface of sternocleidomastoid muscle with its investing fascia. The medial border is com‐
posed of the buccopharyngeal fascia covering the lateral surface of the superior constrictor
muscle. The pterygomandibular raphe, formed by the junction of the buccinator and the su‐
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perior constrictor pharyngis muscles, is the anterior border. In this area parapharyngeal
space has intimate relationship to pterygomandibular space. The posterior border is made
up by the alar fascia and along it parapharyngeal space communicates with the retrophar‐
yngeal space. Superior border is the skull base and inferiorly parapharyngeal space commu‐
nicates with paravisceral neck space. The styloid process and muscles attached to it, together
with surrounding loose connective tissue and stylohyoid ligament, create styloid septum,
dividing the parapharyngeal space into prestyloid and retrostyloid compartments. The pre‐
styloid compartment does not contain any important structures except ascendant palatine
artery, and is closely adjacent to the tonsillar fossa and the medial pterygoid muscle. The
retrostyloid compartment contains internal carotid artery, internal jugular vein, the cranial
nerves IX - XII, and the cervical sympathetic trunk, as well as lymphatic nodes. Paraphar‐
yngeal space can be infected from various sources including the pharynx, tonsils, parotid
gland, submandibular space, retropharyngeal space, masticator space, and local lymph no‐
des. The most frequent source of parapharyngeal infection is peritonsillar abscess. [162]
Complications arising from infections of the parapharyngeal space are caused predominant‐
ly by involvement of the retrostyloid compartment. They include Horner’s syndrome or cra‐
nial nerves IX to XII palsies. Involvement of the vagus nerve or laryngeal edema and
obstruction can lead to sudden death. Suppurative jugular thrombophlebitis (Lemierre syn‐
drome) is characterized by an anaerobic septic thrombus occluding the internal jugular vein,
often with bacteremia and metastatic foci of infection. [163] Carotid artery erosion and rup‐
ture also can occur, with devastating consequences, characteristically preceded by small
‘‘herald bleeds’’. [164] In addition, infections of the parapharyngeal space can spread to oth‐
er spaces of the head and neck.
11.2.1. Clinical presentation and diagnosis
The clinical manifestations of the parapharyngeal space infection depend on whether the
prestyloid, retrostyloid or both compartments are involved. The clinical symptoms of infec‐
tion of the prestyloid compartment are dysphagia, trismus, and pain involving the ipsilater‐
al side of the neck with potential projection to the ipsilateral ear. Flexion of the neck
intensifies pain by physical compression of the space. On physical examination, swelling
and induration may be noticed at the angle of the mandible and parotid area. When an ade‐
quate oro-pharyngeal examination is not hampered by trismus, the lateral pharyngeal wall
is often found displaced medially. There may be other physical findings associated with the
portal of infection, like tonsillitis or pharyngitis. However, often the infection focus does not
cause prominent symptoms. An antecedent pharyngitis or tonsillitis may already have re‐
solved. Isolated infections of the retrostyloid compartment of the parapharyngeal space lack
the intense trismus associated with prestyloid compartment infections. Occasionally, the pa‐
rotid gland, which is adjacent to the retrostyloid compartment, may become swollen. Edema
may involve the epiglottis and larynx, leading to dyspnea. An oropharyngeal examination
may miss swelling of the pharyngeal wall because the swelling can be hidden behind the
palatopharyngeal arch. Some of patients thus have no specific localizing signs and may
present with sepsis of occult origin. The diagnosis may become apparent only on imaging or
after the development of neurologic or vascular complications. Infections of either compart‐
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ment are associated with systemic toxicity, fevers, chills, and potentially rigors. [90, 161]
(Figure 21).
 
 
 
 
 
 
 
 
 
 
Figure 21. A. Huge neck abscess previously managed by insufficient incision and antibiotic therapy. B. CT scan with
contrast shows displacement of airway and compression of great vessels. C. Drainage of abscess by liberal neck inci‐
sion.
11.2.2. Treatment
Infections of the parapharyngeal space, especially prestyloid compartment, are usually sup‐
purative and have tendency to spread rapidly. They should be managed by early surgical
drainage and antibiotic therapy. Some authors suggest that infections localized to the retro‐
styloid compartment with no clinical evidence of sepsis or airway compromise may respond
to intravenous antibiotics without surgery. [165] These two forms can be differentiated by
contrast CT scans. [166]
11.3. Retropharyngeal abscess
The retropharyngeal space is surrounded anteriorly by the posterior wall of the pharynx, su‐
periorly by occipital bone and bilaterally by loose connective tissue contiguous with both
parapharyngeal spaces. The posterior wall is made up by the alar fascia derived from the
deep layer of cervical fascia. Retropharyngeal space extends caudally and communicates
with the mediastinum. Retropharyngeal abscesses occur more frequently in children. It is
surmised that young children are more prone to retropharyngeal abscesses due to the nu‐
merous lymph nodes in the space, while in adolescents and adults retropharyngeal lym‐
phatics are regressed [167]Retropharyngeal abscesses in adult age occur mostly in
immunocompromised patients or as a foreign body complication. [168]
11.3.1. Clinical presentation and diagnosis
Clinical manifestations of retropharyngeal space infections and abscesses can vary from
mild retropharyngeal pain and malaise to severe respiratory distress and systemic toxicity.
Patients often experience an abrupt onset of high fever that is associated with drooling, dys‐
phagia, neck pain on hyperextension, and dyspnea. Respiratory distress can develop be‐
cause of the anterior displacement of the pharyngeal wall and the supraglottic structures.
On transoral examination, bulging of the posterior oropharynx may be seen or palpated, al‐
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though palpation of the lesion may lead to abscess rupture with aspiration or asphyxiation.
The oropharynx can be examined carefully, only in a cooperative patient, who should be
placed in the Trendelenburg position. Suction equipment must be ready in the event of ab‐
scess rupture. [90,161] The CT scan is the gold standard imaging technique, and plays a criti‐
cal role in surgical decision-making. Described abnormalities are the presence of fluid-like
opacities with rim enhancement, scalloping, gas collections, soft-tissue swelling, and obliter‐
ated fat planes.
11.3.2. Treatment
Management includes intravenous administration of antibiotics and drainage of the abscess.
Intraoral approach is currently the preferred route. A needle aspiration might be a sufficient
treatment when it retrieves pus. If not, the surgical procedure should be completed by inci‐
sion and drainage. Most abscesses can be drained by peroral incision and suction. When the
risk of airway obstruction is great, tracheostomy may be needed. External incision is re‐
quired rarely, when the abscess is extending laterally to the great vessels or inferiorly to‐
wards the mediastinum. [90] However, several studies dealing with pediatric population
pointed out the poor correlation between CT scan abnormalities and pus finding during the
surgery [169] or reported successful treatment of CT diagnosed abscesses by antibiotics
without surgery. [170]
11.4. Danger space and prevertebral space infections
The danger space is located posterior to the alar fascia and is bounded by the prevertebral
fascia posteriorly. It is delineated superiorly by the base of the skull; inferiorly it extends
through the posterior mediastinum to the diaphragm. Infections of the danger space usually
develop by direct spread from adjacent spaces. Infections of danger and prevertebral space
can extend throughout the posterior mediastinum and may involve the retroperitoneum.
Occasionally, the purulent material from the posterior mediastinum ruptures into the pleu‐
ral cavity, causing a pyothorax and secondary pleural effusions. Another feared conse‐
quence of mediastinal invasion is pericarditis with pericardial effusion and potentially
tamponade. [162] The prevertebral space is the crevice between the prevertebral fascia and
spinal column. It extends from the base of the skull down to the coccyx and is contiguous
with the sheath of psoas muscle. Infections of the prevertebral space usually develop from
hematogenic osteomyelitis/discitis of the cervical spine. They can also result from iatrogenic
penetrating injuries of the trachea or esophagus. Infections of the prevertebral space behave
in a different manner from infections of the retropharyngeal and danger spaces. Complica‐
tions commonly arise from spinal epidural cord compression resulting in paralysis. They
can also lead to psoas muscle abscess, because of the open communication of the preverte‐
bral space down to the psoas muscle. Infections of the vertebrae or disc may cause local de‐
struction with mechanical instability of the spine. [162]
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11.5. Bezold’s abscess
Bezold’s abscess occurs when a purulent mastoiditis erodes the bone of the mastoid tip. The
infection process is prevented from reaching the skin surface by the intervening neck mus‐
culature. When left untreated, the pus can track along the fascial planes of the digastric or
sternocleidomastoid muscles and spread downward to the carotid sheath. The classic Be‐
zold’s abscess was first reported in 1881 following a cadaver study in which pus was found
to track from the medial side of the mastoid process through the incisura digastrica. Treat‐
ment consists of incision and drainage of neck abscess and elimination of mastoid infection
in addition to wide spectrum antibiotics. [171] (Figure 22)
 
 
 
 
 
 
 
 
 
 
Figure 22. A. Patient treated for otitis media developed painful neck swelling with torticollis. B. CT examination re‐
vealed abscess cavity involving the right sternocleidomastoid muscle. C. The abscess was drained from two neck inci‐
sions placed in skin creases.
11.6. Cervical Necrotizing Fasciitis
Cervical necrotizing fasciitis (CNF) is a rapidly progressing destructive, polymicrobial infec‐
tion that spreads alongside deep fascial planes of the neck. It most frequently develops from
odontogenic sources, but can be also caused by progression of tonsillar and pharyngeal ab‐
scesses, injury to the tissues by a foreign body or catheterization, and postoperative wound
infections. If not treated promptly and radically, it can reach the thorax and develop into de‐
scending necrotizing mediastinitis. CNF complicated by mediastinitis has 41% mortality ac‐
cording to the recent literature review. [172] (Figure 23)
 
 
 
 
 
 
 
Figure 23. Fig. 23. A. Involvement of neck and upper chest wall with necrotizing fasciitis. B. CT scan shows extensive
hallmark gas formation.
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General principles of diagnosis and management of NF are described in the previous section
dealing with facial skin infections. Early aggressive incision and drainage and debridement,
along with close surveillance with repeat CT scans and retreatment, when indicated, are
compulsory if any chances for favorable outcome are to be retained. No definitive treatment
for descending necrotizing mediastinitis has been established. The primary treatment cur‐
rently involves drainage through a combined cervical and thoracic approach, although some
authors believe that cervical drainage alone is sufficient. [173]
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